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CHAPTER I
INTRODUCTION
INTRODUCTION
For centuries iron was regarded as a source of 
health and vigour, and it has been known for at 
least 200 years that it is a component of blood 
and effective in the treatment of chlorosis. However, 
its metabolism remained largely a mystery until 
the advent of radioactive iron isotopes in 1938.
Since then most of the major pathways of this 
metal into, through and out of the body have been 
elucidated. In addition the functions which it 
subserves have been partially characterized.
Iron performs its most critical function in
the body in combination with protoporphyx’iu to
/
form haem. Haem plus various protein moieties form 
compounds which bind oxygen reversibly. Haemoglobin 
in ex’ythx'ocytes transports oxygen from the lungs 
to the periphery, while myoglobin enables muscle 
cells to store oxygen. In the tissues haem enzymes 
such as the cytochromes are concerned with oxidative 
metabolism. Iron compounds are thus pivotally 
involved in the basic energy-exchange reactions of
cellular metabolism
The human body shows great economy in its 
handling of iron and only small amounts are lost 
each day. Iron is thus rigidly conserved by the 
body (McCance and Fiddowson, 1938) and this serves 
to emphasize its metabolic importance. The total 
iron content of an average adult varies between 
2 and 5g> values being higher for the male than 
the female (Pritchard and Mason, 1964; Feinfeld, 
1 9 6 5)* The major proportion of body iron is present 
in circulating haemoglobin (approximately 66 0^);
3% is in myoglobin and less than 1 fo is bound to 
transferrin or in the haem enzymes (Bothwell and 
Finch, 1 9 6 2). The remainder comprises the body 
store of iron, which does not appear to participate 
in active metabolic processes. It represents a 
reserve from which iron can be drawn if demands for 
it increase. This has been demonstrated following 
phlebotomy (Haskins et al, 1952), and in iron 
deficiency these stores become depleted (Rath and 
Finch, 1948).
The metabolically active iron-containing 
compounds in the body are continually being renewed, 
the iron being used again and again as fresh proteins
and porphyrins are synthesised. Xn normal indivi­
duals about 3°mg iron passes through the plasma 
pool each day, most of it en route to the erythroid 
marrow where it is incorporated into the haemoglobin 
of developing red cells (Huff et al, 1950). The 
major source of this iron is the reticulo-endothelial 
cells of the liver and spleen, which engulf aged 
erythrocytes and liberate the haemoglobin iron for 
re-utilization (Noyes et al, i9 6 0). Only relatively 
small contributions are made by iron newly absorbed 
from the gastro-intestinal tract and by the body 
iron stores, xvhich. are located principally in 
reticulo-endothelial cells; but the supply from 
these sources is increased if the requirements 
for erythropoiesis are enhanced (Haskins et al,
1952; Hahn et al, 1943). At any moment in time 
only about 4 mg iron is present in the plasma, 
and there is a rapid turnover with a half-time 
of approximately 90 minutes.
Iron transport through the plasma is mediated 
by a specific binding protein known as transferrin.
It is a beta 1 globulin with a molecular weight 
of 74,000 (.Roberts et al, 1 9 6 6). This protein is a
true transport vehicle and is not destroyed in the 
process of acquiring or relinquishing its iron 
(Laurell, 1951)♦ Each molecule of transferrin is 
capable of binding two atoms of ferric iron. There 
is good evidence that transferrin cannot give up 
its iron to reticulo-endothelial cells in vivo 
(Finch et al. 1 9 6 5), or acquire iron from red cell 
precursors. The unidirectional transfer is 
presumably due to the nature of the exchange 
mechanisms at the different cell membranes (Finch 
et al, 1 9 7 0)» Normally transferrin is only -j saturated 
with iron, the concentration representing a dynamic 
equilibrium between the amount of iron entering and 
the amount leaving the plasma at any one time. If input 
exceeds the marrow demand, the plasma iron concentration 
will rise; if demand exceeds supply, the level will 
fall. In normal individuals there is a distinct 
diurnal variation in the plasma iron, values being 
highest in the morning and lowest in the late evening 
(Laurell, 1953)• This is reversed in normal subjects 
who work at night (fiowie et al, 1 9 6 3) and is absent 
in many disease states (Bothwell and Finch, 1 9 6 2).
These daily fluctuations probably represent changes
in reticulo-endothelial iron release (Funk, 1 9 7 0), 
but the mechanism is unknown.
The percent saturation of transferrin with 
iron appears to influence its destination. At 
normal levels of saturation and with normal marrow 
demands, 80 $ of the iron on transferrin is taken 
up by red cell precursors and incorporated into 
haem within one hour (Noyes et al, 1 9 6^). If, 
however, the plasma iron level rises to near 
saturation, either due to decreased marrow demand 
(aplastic anaemia), or increased input (haemochroma- 
tosis), more is deposited in liver parenchymal 
stores (Hosain and Finch, 1 9 6 6). Recently Fletcher 
and Iluehns (1 9 6 7, 1 9 6 8) have suggested that 
functional differences between the two binding sites 
for iron on transferrin account for those observa­
tions. They believe that the one site preferentially 
gives up its iron to the erythroid marrow and 
placenta, while the other is more involved with 
transport to stores. This suggests an active role 
for transferrin in internal iron exchange. The basis 
for this hypothesis is derived from observations 
on the uptake of transferrin iron by reticulocytes
in vitro. In vivo studies, however, have thus 
far not provided support for this attractive 
hypothesis (McChernelch and Brown, 1970, Lane and 
Finch, 1970).
Although most of the iron entering the plasma 
has been newly liberated from haemoglobin in reticulo­
endothelial cells, there is also a contribution 
from storage compounds in these cells and in 
other tissues such as the liver parenchyma. There 
are two storage compounds; haemosiderin, an insoluble 
compoLind which is visible histologically as green 
granules when stained with prussian blue, and the 
soluble ferritin. Ferritin consists of a central 
core of six electron dense, closely associated 
iron clusters (Kerr and Muir, i9 6 0; Bessis and 
Breton-Gorius, i9 6 0), surrounded by a protein 
envelope. The protein shell is made up of about 
20 identical polypeptide chain sub-units and has a 
molecular weight of 460,000 (Harrison, 1 9 6 3). Ferritin 
from different species is immunologically specific 
(Mazur and Shorr, 1948); in addition there are 
electrophoretic differences between ferritins 
derived from liver, spleen and bone marrow (Alfrey
et al, 19^7; Gabuzda and Gardner, 1 9 6 7). By various 
techniques all the iron can bo removed from ferritin 
without demonstrably damaging the protein shell. 
Lacking iron the protein is called apoferritin.
The iron is present for the most part as ferric 
hydroxide-ferric phosphate micelles and accounts 
for 17 to 23‘fo of the dry weight (Granick, 19^2) .
A small proportion of the iron is on the surface 
of the molecule, in the ferrous form, linked to 
sulfhydryl groups (Mazur et al, 1955)* This iron 
is available for transfer to endogenous or exogenous 
chelates, and is in equilibrium with the larger 
centrally situated ferric pool. When the sulf­
hydryl groups are oxidized to disulphide linkages, 
the ferrous ions are also oxidized to the ferric 
form and become attached to the internally situated 
iron micelles. Sulfhydryl groups are essential for 
the binding of iron to fex’ritin. As iron-poor 
ferritin has more sulfhydryl groups than iron-rich 
ferritin, relatively more of the metal binds to the 
former than the latter (Mazur et al, i9 6 0),
The mechanisms involved in the incorporation 
of plasma iron into ferritin have been studied in
vitro, using liver slices (Mazur et al, i9 6 0), and 
in vivo, in the experimental animal (Mazur et al,
1 9 6 1). The postulated mechanism involves inter­
actions between adenosine triphosphate (ATP), 
ascorbic acid and a molecule of iron on transferrin. 
ATP stimulates the oxidation of ascorbic acid in 
the presence of iron. During this reaction the iron 
is reduced to the ferrous form, which dissociates 
from its binding site on transferrin, and is 
transferred to acceptor sulfhydryl groups on the 
ferritin surface. This process is energy dependant.
The entry of iron into a cell results in the 
stimulation of ferritin protein synthesis and in 
addition, stabilizes pre-existing ferritin and 
decreases its rate of degradation (Drysdale and 
Munro, 1 9 6 6). Smith et al (1 9 6 8) have shown that 
iron given orally or parenterally in a single 
dose stimulates ferritin synthesis in the rat 
intestinal mucosa. In iron-loaded rats, rates of 
ferritin synthesis remain persistently higher than 
in normal or iron deficient rats (Cumming et at, 1970)• 
Furthermore, rates of ferritin synthesis appear
to vary proportionally to the amount of iron
given as an oral iron load (Bernier et al, 1 9 7 0).
Studies of iron-induced ferritin synthesis have
shown remarkably similar results in the liver
parenchyma (Drysdale and Munro, 1 9 6 6) and in the
intestinal mucosa (Millar et al, 1970)• Following
a single parenteral dose of iron, the rate of
14incorporation of C-labelled leucine into ferritin 
rapidly increases to a peak at 5 hours and falls to 
normal levels by 8 hours.
Mazur and his associates have also investigated 
some of the factors involved in the release of 
iron from ferritin. On the basis of animal 
(Mazur et al, 1958) and in vitro tissue studies 
(Green and Mazur, 1957), the enzyme xanthine oxidase 
may play a part. Induced hypoxia results in an 
increase of xanthine and hypoxanthine in the 
liver. In the presence of ferritin and under 
anaerobic conditions, hypoxanthine and xanthine 
are oxidized to uric acid by the dehydrogenase activity 
of xanthine oxidase. Ferric ferritin acts as an 
electron acceptor, thereby oxidizing xanthine 
oxidase, and the iron is reduced to the ferrous 
state when it becomes available for transfer out of
the cell. Confirmatory evidence for this hypothesis 
comes from the following in vivo observations 
l) Haemorrhagic or traumatic shock increases both 
uric acid and plasma iron concentrations. 2) Admini­
stration of xanthine, hypoxanthine or inosine 
leads to increased release of iron and uric acid 
from the liver. 3 ) Total hepatic iron stores 
appear to be inversely related to xanthine oxidase 
levels (Mazur and Sackler, 1 9 6 7). 4) Co-existant
haemochromatosis and xanthinuria, a disease 
associated with a congenital absence of xanthine 
oxidase, has been reported (Ayvazian, 1964).
5) Finally, immature rats have increased storage 
iron concentrations and low levels of xanthine 
oxidase. As the concentration of the enzyme rises 
to that found in adult rats, the storage iron 
concentration falls (Mazur and Carleton, 1 9 6 5).
While the above observations strongly suggest a 
central role for xanthine oxidase in the release of 
iron from ferritin, there is other evidence to the 
contrary. For example, a poor correlation between 
changes in body demands for iron and changes in 
measured xanthine oxidase activity has been reported
(Awai and Brown, 1 9 6 9), and patients with xanthin­
uria do not necessarily show changes in iron metabolism 
(Seegmiller et al, 1964). In vitro other reducing 
agents, including ascorbic acid, cysteine and 
glutathione, can release iron from ferritin 
(Bothwell and Finch, 1 9 6 2). The effects of 
allopurinol, a potent inhibitor of xanthine oxidase, 
on iron metabolism are controversial. Some studies 
indicate that it has no effect (Boyett et al. 1 9 6 8; 
Green et al, 1 9 6 8; Awai and Brown, 1 9 6 9), but in 
others changes in iron metabolism have been 
reported. These include an increase in the rate of 
hepatic iron accumulation (Powell and Emmerson,
1 9 6 6), and a decrease in the amount of desferrio- 
xamine-chelatable iron (lledonberg, 1 9 6 9).
The second of the two storage forms of iron, 
haemosiderin, differs from ferritin in that it is 
insoluble and visible under the light microscope. 
Originally haemosiderin was erroneously assumed to 
result from excessive and rapid destruction of red 
cells (Cook, 1929), but there is now a good deal of 
evidence that it is derived partially or wholly 
from ferritin. Studies with the electron-microscope
reveal that the iron granules of haemosiderin have 
an appearance identical to those found in the 
ferritin molecule (Richter, 1958). Furthermore, 
iia vitro oxidation and denaturation of ferritin 
results in granules with the characteristics of 
haemosiderin (Matioli and Baker, 1 9 6 3). Unlike 
ferritin, however, haemosiderin is not homogeneous, 
and its iron, nitrogen and protein contents vary 
(Richter, i9 6 0). It may contain porphyrins, other 
pigments and lipids (Shoden and Sturgeon, i9 6 0). 
Matioli and Baker (1 9 6 3) have postulated the 
following sequence of events in haemosiderin forma­
tion, Ferritin remains freely distributed in the 
cell cytoplasm until it is denatured by oxidizing 
agents. High concentrations of ferritin in the liver 
have been shown to inhibit the enzyme catalase.
As a result, hydrogen peroxide, derived from the 
auto-oxidation of flavoproteins, accumulates.
Hydrogen peroxide is a powerful oxidizing agent 
and may well lead to the conversion of ferritin to 
haemosiderin. The denatured molecules are sequestered 
in vacuoles and aggregate. Until the protein 
component of the molecule is destroyed by tryptic 
digestion, the granule will maintain a fer.rit.inic
substructure. Removal of" the jurotein envelope 
favours the polymerizatIon and precipitation of the 
ferric micelles. This gives rise to the large 
amorphous iron complexes which characterize the 
non-ferritin forms of haemosiderin.
Normally the storage iron in a tissue is 
composed of equal amounts of ferritin and haemosiderin. 
¥hen animals are loaded with iron, there is initially 
an increase in the ferritin. Later, however, 
haemosiderin is deposited while the ferritin 
stabilizes at a constant level (Shoden et al, 19 5 3 ) •  
Haemosiderin iron appears to be less easily 
mobilized from stores than ferritin iron (Shoden 
and Sturgeon, 1 9 6 8).
The size of the body iron stores may be 
investigated during life by several means, but some 
are not suitable for routine clinical practice.
These include estimates of the total iron available 
for1 new haemoglobin synthesis following vigorous 
phlebotomy (Haskins et al, 1952; Pritchard and 
Mason, 19 6 )^, determination of the miscible iron 
stores by radioisotope dilution techniques (Pinch,
1 9 5 9) and histological and chemical evaluation of
iron stores from liver biopsy specimens (Bothwell
and Bradlow, i9 6 0; Prey et al, 1 9 6 8). Furthermore, 
while stainable marrow iron shows a good correlation 
with total iron stores (Gale et al, 1 9 6 3), marrow 
aspiration has some limitations at a clinical level. 
The only two non-traumatic procedures which can be 
used on a wide scale are estimates of the plasma 
iron concentration and total iron binding capacity, 
and measurement of chelatable iron using the iron 
chelate desf erritixamine.
The total iron binding capacity correlates 
well with iron deficiency but cannot be used to 
assess iron overload (Weinfeld, 1970). The 
plasma iron concentration is not a good index 
of iron stores. It remains normal until all the 
storage iron has been mobilized (Bothwell and 
Finch, 1 9 6 2), and although it is often elevated 
if the stores are excessive, it provides no clue 
to the severity of the siderosis. Furthermore, 
in the presence of ascorbic acid deficiency, the 
plasma iron may be only minimally elevated 
despite massive iron overload (tJapnick et al, 1 9 7 0) , 
and some degree of ascorbic acid deficiency is
frequently associated with severe siderosis (Seftel 
et al, 1 9 6 6). In recent years desferrioxamine has 
assumed an important place in the assessment of 
iron stores. Studies on urinary iron excretion 
following a standard dose of desferrioxamine 
indicate that an accurate measure of the size of 
the iron stores may be obtained in this way (Hallberg, 
et al. 1 9 6 6). This approach is discussed in greater 
detail in chapter k .
The immediate source of the iron in the major 
storage depots of the body differs. The liver 
parenchymal cell acquires iron from transferrin.
There are species variations in the percentage of 
the daily plasma iron turnover which enter the liver. 
In rats it is about 15$ (Cheney et al, 1 9 6 7), but 
the figure is considerably less in normal humans 
(Hosain and Finch, 1 9 6 6). The proportion is, 
however, increased in conditions associated with 
a high plasma iron and low unsaturated iron binding 
capacity (Hosain and Finch, 1 9 6 6). Little is 
known of the day to day exchange between transferrin 
and hepatic parenchymal cells, but a mechanism for 
mobilization of hepatic storage iron exists, and
these stores have been shown to be readily available 
for haemopoiesis after bleeding (finch and Finch,
1955).
The cells of the reticulo—endothelial system 
obtain most of their iron from catabolized haemo­
globin, either from senile erythrocytes or from 
wastage during erythropoiesis. Some haemoglobin 
iron leaves the developing red cell with extrusion 
of its nucleus, and some structurally abnormal 
cells with a short life span are phagocytosed 
(Cook et al, 1970)» A small amount of haemoglobin 
bound to haptoglobin is cleared daily by reticulo­
endothelial cells, but this accounts for only a 
minute fraction of recircuited iron (Garby and 
Noyes, 1959a)• There is in addition a small amount 
of free haem in the plasma. This is complexed 
either to albumin, or to a specific haem binding 
protein, haemopexin (Muller-Eberhard, 1970). In 
contrast to haemoglobin, haem is cleared by the 
liver parenchymal cells and may be involved in the 
regulation of haem synthesis in these cells.
The spleen is the major site for sequestration 
of circulating red cells (Crosby, 1959). Non—viable
erythrocytes are cleared exponentially from the circulation,
and there is some evidence that the most severely
damaged cells are preferentially removed (Noyes
et al, i9 6 0). Splenectomy in rats results in a
slowed rate of clearance of acetyl-phenylhydrazine
damaged cells (Azen and Schilling, 1 9 6 3). The
survival of the normal red cell depends on its
ability to deform (Need, 1970)• This property
enables cells with a diameter usually greater than
8yu to pass through splenic channels with diameters
less than 3yU. With age, an alteration in the red
cell membrane occurs; it becomes more rigid and
thus the cell is trapped in the splenic sinusoids.
Effete red cells have been shown to adhere readily 
to hepatic, splenic and alveolar macrophages 
(Lee and Cooper, 1 9 6 6), but the mechanism whereby 
the phagocytes recognize and clear altered red cells 
is poorly understood, The initial phase of 
phagocytosis is thought to be the adhesion of the 
red cell to a receptor site on a macrophage 
(Rabinovitch, 1964), Contact between the two cells 
results in excitation of the macrophage membrane, 
and phagocytosis follows.
Kornfeld et al, (l9 6 9 ) have followed the
intracellular pathway of sequestered haemoglobin in 
rat livers. Initially the haemoglobin is found 
predominantly in endocytic vacuoles known as phagosomes. 
These particles then merge with lysosomes and thus 
acquire lytic enzymes capable of degrading haemoglobin. 
The iron is released from haem and enters the cyto­
plasm. The nature of this in transit iron is unknown.
It may then either leave the cell or be incorporated 
into ferritin. Very little is known of the factors 
which determine how much iron is released into the 
plasma and how much is diverted into the stores: 
this topic is examined in greater detail in chapter 2. 
There is no doubt, however, that considerable 
variation does occur, and that supply matches 
erythropoietic demand reasonably closely under most 
circumstances.
While transferrin is undoubtedly the principal 
acceptor of iron from the reticulo—endothelial system, 
there is some electron-microscopic evidence that reticul 
endothelial cells in the marrow can deliver iron 
in the form of ferritin directly to erythroblasts.
Bess.is and Breton-Gorius (1 9 6 2) have shown that
developing red cell precursors tend to group around 
a reticulum cell, the "nurse-cell", and ferritin 
can be seen in the cytoplasm of both cells and in 
invaginations of the membrane (ropheocytosis). 
However, it is possible that the direction of 
ferritin movement is from the red cell precursor 
to the reticulum cell, and that e x c e s s  iron is 
being excreted in this way. Some support for this 
interpretation is provided by the evidence that 
splenic reticulum cells can extract ferritin 
from siderocytes (Crosby, 1957)* Even if iron does 
enter erythrocyte precursors in this way, quantita­
tive considerations make it clear that it can 
constitute only a tiny fraction of haemoglobin iron.
The iron bound to transferrin is in the ferric 
form, whereas there is suggestive evidence that 
iron released from ferritin is in the ferrous form. 
If this is so, it must be oxidised before or during 
binding to the transport protein. Caeruloplasmin, 
which is present in the plasma, accelerates the in 
vitro oxidation of iron from the ferrous to the 
ferric form (Osaki et al, 1^66; Osaki, 1 9 6 6), and
Cartwright and co-workers have provided elegant
evidence for the role of this enzyme in iron 
metabolism. In copper deficient swine the iron 
in intestinal mucosal cells, reticulo~endothelial 
cells and liver parenchymal cells is not given 
up to transferrin. In contrast, the ability of 
these cells to take up iron and to incorporate 
the metal into ferritin is not impaired (Lee et al. 
1 9 6 8). The defect in iron metabolism is corrected 
immediately by the injection of caeruloplasmin, 
but not by administration of equivalent amounts 
of copper (Ragan et al, 19 6 9)• This suggests 
that the enzyme itself (and not the copper) is 
responsible for iron release to transferrin. 
Measurement of plasma caeruloplasmin levels 
indicate that it must fall to below I'fo of normal 
values before abnormalities of iron metabolism are 
noted (Roeser et al, 1970)• This suggests that 
the enzyme subserves a permissive function, and 
may well not be involved in the day to day 
regulation of reticulo—endothelial iron release.
It must be noted, however, that in pathological 
states such as haemolytic anaemias, the amount 
of caeruloplasmin required to maintain the elevated 
plasma iron turnover increases markedly.
Although oxidation, of the iron is thus necessary 
before it can be taken up by transferrin, the 
preceding step seems to be a reduction, since 
ferritin iron is predominantly in the ferric form. 
There is some evidence that ascorbic acid may be 
involved at this stage. In siderotic Bantu of 
South Africa who develop scurvy, plasma iron levels 
are reduced. Administration of ascorbic acid 
to such subjects results in a prompt rise in 
plasma iron without an associated reduction in 
plasma iron turnover (Bothwell et al, 19 6 k ) ,  The 
interrelationships between ascorbic acid and iron 
metabolism will be discussed further in Chapter 3*
It is apparent from this review of the current 
state of knowledge of iron metabolism in the reticulo­
endothelial system that there is a fair degree of 
insight into certain aspects, but that much remains 
to be elucidated. The experiments described in this 
thesis were designed to gain further information about 
three particular areas of uncertainty, namely, 
the mechanisms involved in the variable release of 
liberated haemoglobin iron into the plasma, the 
source of iron chelated by desfer.rioxam.ine and 
the role of ascorbic acid in storage iron metabolism.
S O M E  F A C T O R S  A F F E C T I N G  T H E  R E L E A S E  O F  I R O N  
F R O M  R E T I C U L O — E N D O T H E L I A L  C E L L S
INTRODUCTION
As already indicated in Chapter 1, the major 
source of the iron entering the plasma pool is the 
haemoglobin from senile erythrocytes which have been 
engulfed by reticulo-endothelial cells, and its 
major destination is the erythroid marrow where it 
re-enters the red cell cycle. Prom the limited 
data available it would appear that under physiologi­
cal conditions, little of the iron from catabolized 
haemoglobin exchanges with storage iron (Garby and 
Noyes, 1959^ *) > and most of it is released. If, 
however, a larger load of non—viable erythrocytes 
is injected, more than half the iron remains within 
the reticulo-endothelial cells (Noyes et al, i9 6 0).
The rate of entry of iron into the plasma varies 
under the influence of a number of factors. One of 
the most important of these is the rate of erythrop- 
oiesis. Venesection has been shown to increase 
iron release, so that even when large quantities 
of non-viable red cells are injected, almost all the 
iron from catabolized haemoglobin enters the 
circulation (Noyes et al, i9 6 0). The supply of 
iron is thus adjusted to meet the requirements 
of the erythroid marrow, but the response of the
reticulo-endothelial system is not immediate. An
increase in the rate of erythropoiesis following 
ascent to high altitudes is at first followed 
by a fall in the plasma iron concentration; 
within a few days, however, the rate of delivery 
of iron to plasma is accelerated, and the concentra­
tion returns to normal even though the plasma iron 
turnover is increased (Reynefarje et al, 1959)• 
Furthermore, experiments with rats using an altitude 
chamber have shown that the plasma iron is considerably 
elevated 7 days after returning to normal atmospheric 
pressure (Weintraub et al, 1 9 &5 ) • In patients with 
aplastic anaemia, a marked fall in plasma iron turn­
over is noted, which indicates that the reticulo­
endothelial system can conserve iron not required 
for erythropoiesis (flosain and Finch, 1 9 6 6). The 
reticulo-endothelial system cannot, however, retain 
all the iron from catabolized haemoglobin. Even in 
aplastic anaemia half of it is released to the circu­
lation, and a marked rise in plasma iron concentra­
tion results (Finch et al, 1970)*
In pernicious anaemia, kinetic data reveal a 
plasma iron turnover which is 3 ~  ^times normal.
Plasma iron levels are usually elevated (Finch etal, 
1 9 5 6), indicating that the reticulo-endothelial system 
supplies iron in amounts adequate to meet the demands 
of the hyperplastic marrow. Most of the new red cells 
are, however, destroyed before entering the circulation. 
With treatment, ineffective erythropoiesis ceases, and 
the major source of iron supply to the marrow is elimin­
ated. This is reflected in a rapid fall both in plasma 
iron and plasma iron turnover in spite of the reticu­
locyte crisis. Thalassaemia affords an even more 
impressive illustration of the capacity of the reticulo­
endothelial system to process haemoglobin iron (Finch 
et al, 1970)• While the plasma iron turnover may be 
10 times normal in this condition, plasma iron concen­
trations are usually elevated. From these data it 
would seem that the amount of iron released by the 
reticulo-endothelial system depends on the amount of 
iron entering the system. This has been confirmed 
experimentally. When increased loads of non-viable 
erythrocytes are administered to normal subjects, a 
proportional increase of reticulo-endothelial iron 
release is noted (Noyes et al, i9 6 0).
Little is known about the factors controlling 
the entry of reticulo-endothelial iron into the
plasma. Following venesection, the increased marrow 
demand results in a fall in plasma iron, with a 
corresponding rise in percent transferrin saturation. 
Pollycove (1 9 6 6) has proposed that it is this that 
stimulates increased iron release from stores until 
supply meets demand. As the anaemia becomes less severe, 
the rate of iron removal by the marrow decreases, the 
plasma iron rises and thus transfer from stores diminishes. 
This hypothesis has, however, as yet no experimental 
evidence to support it. Furthermore, saturation of 
circulating transferrin with ionic iron does not 
decrease the re-utilization of a load of non-viable 
erythrocytes given two hours later (Noyes et al, i9 6 0).
There is little evidence that any other factors 
are involved. Most hormones probably do not directly 
alter iron handling by the reticulo-endothelial system. 
Adreno-corticotrophic hormone or cortisone do not alter 
plasma iron concentrations (Paterson et al, 1952).
Plasma iron turnover is reduced in myxoedema and in­
creased in thyrotoxicosis (Finch et al, 1970)> but 
this may merely reflect the effect of thyroxin on 
erythropoiesis. Red cell production is reduced
in myxoedema and increased in thyrotoxicosis, but
the rate of erythropoiesis is under the direct 
control of erythropoietin. The possibility that 
erythropoietin enhances reticulo-endothelial iron 
supply has been considered, but there is some 
evidence that it does not directly stimulate 
reticulo-endothelial iron release. In response 
to altitude induced hypoxia, the increase in 
plasma iron turnover lags well behind the rise in 
circulating erythropoietin levels (Paura et al,
1 9 6 9). Furthermore, while plasma erythropoietin 
levels are usually elevated in aplastic anaemia 
(Lange et al. 1 9 6 1), reticulo-endothelial iron 
release is markedly reduced.
A number of disease processes are accompanied 
by inefficient entry of iron into the plasma, as 
evidenced by a modest anaemia and a low plasma 
iron concentration din the face of normal or 
increased reticulo-endothelial iron stox’es 
(Cartwright and Wintrobe, 1952). Ferroklnetic 
data in chronic infections, malignancy and rheumatoid 
arthritis, are remarkably similar (Bush et al, 19 5 6;
Chodos et al, 1956; Freireich et al, 1957a). Evidence 
of impaired roticulo-endothelial iron release has
been obtained, botli in animals (Freireich et al,
1 9 5 7b) and in man (llourani et al, 1 9 6 3; Hourani 
et al. 1 9 6 5). ¥hile restricted iron supply may well 
be the prime defect in these anaemias, other abnor­
malities have been noted. These include a shortened 
red cell survival due to an extra-corpuscular 
factor (Freireich et al, 1957a), and an inadequate 
erythropoietin response (Gutnisky and Van Dyke,
19b3)* Cartwright (l9 6 6 ) believes that relative 
erythropoietin lack results in a failure of the 
marrow to compensate for the shortened red cell 
survival. He reasons that once the anaemia has 
reached a steady state, reticulo-endothelial iron 
release is again appropriate, in that output equals 
the input from a reduced red cell mass. He 
believes that the experimental results indicating 
impaired iron release may be explained on the 
basis of dilution of the radioactive label in the 
enlarged intra—cellular iron pool. It must be 
noted however, that direct estimates of erythro­
poietin levels have not been made in these 
disorders, and that all the features of the anaemia 
may be explained on the basis of relative iron 
deficiency due to impaired reticulo-endothelial release.
While there is thus some doubt that iron 
release is impaired in these chronic diseases, 
it is clear that in acute infections the reticulo­
endothelial iron supply is markedly diminished.
In man, hypoferraemia develops early in the course 
of febrile illnesses (Cartwright and Wintrobe, 1952). 
Administration of small doses of endotoxin to rats 
causes a rapid fall din both plasma iron and plasma 
iron turnover (Kampschmidt and Arrendondo, i9 6 0).
Soon after turpentine abscess formation, rats 
show impaired re-utilization of catabolized haemo­
globin iron. In addition, the rate of sequestration 
of non-viable erythrocytes by the reticulo-endothelial 
system is increased (Quastel and Ross, 1 9 6 6). The reasons 
for these alterations in reticulo-endothelial function 
are, however, not understood.
Because of the paucity of information about the
factors involved in the regulation of iron supply from
the reticulo-endothelial system to the erythroid
marrow via the plasma pool, the studies described in
this chapter were undertaken. The experiments were
performed with rats, and reticulo-endothelial function
59was assessed by examining the release of F e from the
liver and spleen after injecting heat-denatured
59erythrocytes containing Fe-haemoglobin.
M A T E R I A L S  A N D  M E T H O D S
Adult male rats of the Sprague-Dawley strain, 
weighing between 200 and 300g were used. In each 
study rats were matched for weight, the maximal 
difference being 25g. They were housed in cages 
containing a maximum of 6 animals, and received a 
diet of rat production pellets (Delmas Milling 
Company, Randfontein, South Africa) and tap water.
In some studies erythropoiesis was inhibited
by hypertransfusion or stimulated by venesection.
Rats were hypertransfused by intravenous injections
of 4ml packed erythrocytes on the eighth and seventh
day prior to starting the experiment, In other
animals erythropoiesis was stimulated by removing
4ml blood from the retro-orbital plexus of veins
\
on the sixth and fifth day before the start of the 
experiment. To ensure that significant changes in 
erythropoiesis had occurred, incorporation of 
transferrin-bound radioiron into circulating 
erythrocytes was measured in 5 hypertransfused,
5 normal and 5 venesected rats.
Radioiron bound to transferrin was prepared 
by incubating buffered plasma with tracer amounts of
59 oFeCl^ for 30 minutes at 37 C. The amount of
59FeCl^ added was always less than the binding 
capacity of the plasma present. After h h hours 
the animals were weighed and bled to death via the 
aorta. The packed cell volume and the radioactivity 
present in a 2ml sample of washed erythrocytes were 
determined. The mean (isD mean) percentage red 
cell utilization of radioiron (calculated on the 
assumption that the blood volume was 50ml/kg body 
weight in normal and venesected animals and 60ml/kg 
body weight in hypertransfused animals) was 9 (~4)$, 
7 5 (i8 )/o and 95 (-3 )/° in hypertransfused, normal and 
venesected animals respectively. The mean (isD mean 
packed cell volumes were 6 3 (~3 )^ > 5l(—2)^ and 
33(^2)$.
/ 59 \Erythrocytes containing ( Fej-haemoglobin
were obtained from a rat given weekly injections
59of 50y a c Fe intraperitoneally in the form of
fei’rous ascorbate. The radioactive solution was
59prepared by adding the ^ yF e C l ^  to 1ml sterile 
isotonic saline containing lOOmg ascorbic acid. 
Immediately prior to the start of the experiment 
blood was obtained in heparin from the retro-orbital
plexus of veins. After centrifugation and aspiration 
of plasma the erythrocytes were washed in sterile 
isotonic saline and then suspended in four times 
their original volume of a 1 : 1  mixture of isotonic 
saline and ACD (5g citric acid, 13.89g sodium citrate 
and 13.9g dextrose per litre of solution). They 
were denatured by heating for 25 minutes at 40°C.
Once the erythrocytes had been damaged, the
haemoglobin concentration was determined so that
the amount of iron could be calculated. The cell
suspension was then diluted in isotonic saline,
and each experimental animal received in 1ml the
required amount of haemoglobin iron. Cells damaged
%
in this way were taken up approximately equally by 
the liver and spleen. The temperature influenced 
the site of sequestration of the damaged erythrocytes; 
when cells were heated to b^°G a much greater 
percentage was cleared by the liver, At this 
temperature varying degrees of haemolysis were noted 
and a significant percentage of radioactivity was 
lost in the urine. Even when a standard procedure 
was followed, however, the relative proportions 
taken up by the two organs varied. In some experiments
mom radioactivity \^ as cleared by the spleen, in 
others more by the liver. The reasons for this 
variation were not elucidated.
In some studies injections of denatured
unlabelled erythrocytes were given to rats before
5 9the cells containing Fe. The unlabelled cells 
were treated in the same way as the radioactive 
erythrocytes. In other studies iron was injected 
intravenously in the form of iron—nitrilotriacetic 
acid (NTA—iron). Nitrilotriacetic acid was 
dissolved in isotonic saline adjusted to pH 9*0 
with solid sodium bicarbonate, and the pH was 
then lowered to 3*0 with concentrated hydrochloric 
acid. Iron was added as FeCl^ in a molar ratio of 
iron to NTA of 1:2, and the pH finally raised to 
7.0 with sodium bicarbonate. The concentration of 
iron was adjusted to 10 0yug/ml.
Rats received intravenous injections via the 
tail veins, A Packard whole-body Armac counter was 
used to measure the total amount of radioactivity in 
the animals. At timed intervals groups of animals 
were killed by bleeding from the aorta under ether 
anaesthesia. Their livers and spleens were removed
and cooled rapidly in crushed dry ice. The radio­
activity in the organs was determined and expressed
59as a percentage of 'Fe injected. They were stored 
at - 20°C until fractionation was performed.
The stored liver and spleen from each animal 
were thawed and homogenized together in four times 
their weight of distilled water. To ensure minimal 
geometric errors all samples were made up to the same 
volume, and the radioactivity was assessed by means 
of a well-type scantillation counter. Total 
radioactivity present in the combined liver and 
spleen was calculated from a 2ml aliquot of the 
homogenate.
59Fe in ferritin was determined by heating a 
4ml aliquot of the homogenate to 80°C for 10 minutes 
(Drysdale and Munro, 19^5)• When cool, the sample 
was centrifuged at 1,500 X g and an equal volume of 
saturated ammonium sulphate was added to the 
supernate. After standing at 0°C for two hours to 
allow complete precipitation, it was centrifuged 
and the radioactivity in the precipitate was
determined
The method was checked by determining the
recovery of labelled ferritin which had been added
to a non-radioactive rat liver homogenate. The
(-^Fe)—ferritin was prepared by the above method
from the liver of a rat killed one hour after 30yug
59iron' as ferrous sulphate labelled with 10yuc FeCl^
had been injected intravenously. The mean (isD mean)
percentage recovery in 5 experiments was 91
/59 \The possibility that ( Fe) —haemoglobin might
contaminate this fraction was examined by adding 
/ 59 \\ F e )-haemoglobin to a non—radioactive liver 
, 59 \homogenate. ( Pej-haemoglobin solution was obtained 
by lysing in ice-cold distilled water washed 
erythrocytes labelled in vivo, and removing the 
stroma by centrifugation. In 5 experiments a mean 
(isD mean) of only 0.75(~0,2)% of the radioactivity 
was found in the ferritin fraction.
As a final validation, the method was compared 
with the immunological Isolation of ferritin. An 
antiserum to crystalline horse spleen ferritin was 
prepared in rabbits by the method of Mazur and 
Shorr (1 9 -^8). This antiserum cross-reacts with 
rat liver f err it in (Mazur et al, i9 6 0), and 0. ,5ml
was found to precipitate 190^ug ferritin iron. Two
rats were killed Zk hours after an intravenous injection
of transferrin-bound radioiron. The livers were
removed and 4ml aliquots of the homogenate from each
organ were transferred to 10 test tubes. The heat
supernates were obtained as described above, and the
radioactivities determined. An equal volume of
saturated ammonium sulphate was added to half the tubes %
and 1ml of ferritin antiserum was added to the remainder. 
The former were kept at 0°C for 2 hours and the 
latter incubated at 37°C for one hour. After 
centrifuging the radioactivities of the precipitates 
were measured. By the ammonium sulphate method the 
mean (isD inean)/& labelled ferritin in the livers of the 
two rats was 5^(-^)^° and 6 3(^6)$., respectively, while 
by the antiserum technique the figures were 5 2(^3 )$ 
and 6 5(i4)$. It was concluded that the ammonium 
sulphate method gave very similar results to the 
specific anti-serum. Furthermore, while other 
heat stable proteins exist in rat liver homogenates, 
these must contain minimal, if any, radioiron and 
could be ignored.
Organ radioactivity in the form of haemoglobin 
was determined by the method of Gale et al (1 9 6 3).
5ml saturated sodium pyrophosphate and ^m l 20fo 
trichloracetic acid were added to a 1ml aliqtiot 
of the original homogenate. After heating to 80°C 
for 10 minutes and cooling, radioactivity in the 
washed precipitate was determined.
The method was checked by determining the
, 59 .recovery of  ^ Fe;-haemoglobin added to non-radio- 
active liver homogenate. Mean(isD mean) percentage 
recovery from 5 samples was 9 5(-2 )^ .
In order to discover whether this fraction was 
significantly contaminated with ferritin, the above 
procedure was repeated, but labelled ferritin was 
substituted for (^Fe)— haemoglobin. A mean (iSD mean) 
of only 0 . b ( - 0 . l ) < f o  of ferritin radioiron was found 
in the haem precipitate.
Serum iron concentrations were measured by the 
method of Bothwell and Mallet (1955) and unsaturated 
iron binding capacities by that of Herbert et al
(1967).
The rate of clearance of heat damaged erythro-
, 59 ,cytes labelled with { Fe)-haemoglobin or of trans­
ferrin-bound radioiron was assessed in some experiments.
serumWhen transferrin-bound radioiron was injected, 
rather than plasma was used as it was found that 
heparin tended to cause excessive blood loss. 0,2ml 
blood was removed from the retro-orbital plexus of 
veins exactly 1 0 , 20 and 30 minutes after injection. 
The animal was anaesthetized with ether and the blood 
removed by gently inserting a capillary tube behind 
the eye, Once the required amount of blood had been 
obtained, the tube was removed and excessive bleeding 
prevented by applying firm digital pressure to the 
orbit. At 60 minutes the animal was bled to death, 
and the radioactivity present in plasma and in washed 
erythrocytes determined. All samples were made up 
to 2inl with isotonic saline prior to counting. The 
half time of clearance of injected radioactivity was 
obtained by plotting the results semi-logarithmically.
RESULTS
UPTAKE OF DENATURED ERYTHROCYTES AND RELEASE OF 
IRON IN NORMAL RATS.
59Heat-denatured Fe-labelled erythrocytes
containing 50yug iron as haemoglobin were
injected intravenously into five rats, and the
rate of disappearance was followed. The mean
half—disappearance time (i SD mean) was 18(i l)
59minutes. The subsequent fate of the Fe was
followed in 40 further rats (Table i). One hour
after injection a mean, (i SD mean) of 87 (— 4)$
of the injected radioactivity was in the liver
59and spleen. The Fe was equally distributed 
between the two organs, mean figures (i SD mean) 
being 43(” 8)$ in the liver and b b (i 9 ) (f° in the 
spleen. At this time 78(i 7)$ was still in the 
form of haemoglobin, while 5 (~ 2)/° had already 
been converted into ferritin (Fig l). Four 
hours after injecting the denatured erythrocytes, 
the mean percentage (i SD mean) of the ^ Fe still 
present in the liver and spleen was 5 0(~ 7 ) i° ,  
with 2b (A 5 )/° in the liver and 26 (^  b)°/o in the
TABLE I
UPTAKE, RELEASE AND INTRA—CELLULAR DISTRIBUTION OF "^Fe FOLLOWING THE INJECTION
OF DENATURED ERYTHROCYTES CONTAINING pOyUg HAEMOGLOBIN IRON LABELLED WITH ^ F e
Hours alter 
injecting 
labelled cells Mean /o Injected Radioiron (-SD) /Ug/lOOml
Liver and 
spleen
Ferritin Haemoglobin Liver Spleen Serum
Iron
UIBC
1 87(-4) 5(-2) 78(£7 ) 4 3 (is) 1 8 2(£2 8) 2 6 2(£3 2)
4 50(^7) 2 5 ( ~ 6 ) 14(£4) 24(£5 ) 2 6(£4) 272(£ 9 8) l6o(£55)
24 4l(i4) 2 6 ( ± 5 ) 1 1 (£4) i9(i2) 2 2(£4) 1 5 0 (£2 8) 3 0 6(£2 1)
4o
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59of Fe in combined livers 
times after injecting 
containing ('^Fe)-haemo­
globin Stippled, haemoglobin; shaded ferritin
spleen. Only l4(i 4)^ & was still in the form of 
haemoglobin, while 25 (^  6)^ 'was in ferritin. 
Approximately 37$ had therefore been released 
between one and four hours. The mean serum iron
from l82(i 28)yug/100 ml'at one hour. The rate of
59release of Fe during the succeeding 20 hours 
was considerably slower, since 24 hours after 
injecting the labelled red cells the mean 
radioactivity (i SD mean) present in the two 
organs was 4l(^ 4 ) (fo. In subsequent studies 
attention was therefore focussed on the early 
phase of major release of labelled iron between 
one and four hours.
The effect of varying the load of denatured
erythrocytes was then examined in groups of eight
rats each (Table II). The pattern was remarkably
similar whether the amount of labelled iron in
the haemoglobin was 10yug, 25yUg, 50yug or 10 0yig
(Fig 2). Although the percentage of injected 
59Fe present in the two organs after one hour was 
slightly less with 10yug than with 100yug the
(i SD mean) being 83(- and 94(— 4 ) (Jomeans
TABLE II
EFFECT OF VARYING THE LOAD OF DENATURED ERYTHROCYTES CONTAINING (^Fe) -HAEMOGLOBIN ON THE 
DISTRIBUTION OF INJECTED RAD10IRON
Quantity of Hours after Mean $ Injected Radioiron (Is d ) /ug/lOOml
haemoglobin iron injecting ... * ...... —............ . ■ - — —.... — .. ...■ ■
in labelled cells labelled cells Liver & Ferritin ' Haemoglobin Liver Spleen Serum UIBC
spleen Iron
10 ;Ug / 14
14(14 
35 ("5
47
22
1 2 7(JlO)
152(119) 348(i4l) 313(-52)
25yug
50yug
Released 36 25 11
1
4 8951
8 (i2
36(16
83
13
h o ( t 9
20(14 49(111) 170(120) 29331(14) 192(142) 259
Released 38 20 18
1
4
io(l424(16 80(1912(13
h h f y
3o(l3
43(14
20(16
176
261
230(132)
1 7 2 (l2l)
Released 37
100yug
Released 34
14 94 (146o(l6 25(13
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Figure 2. Effect of varying the load of denatured 
labelled erythrocytes upon the release of iron from 
hepatic and splenic reticulo-endothelial cells. Mean 
values (i SD mean) in rats given denatured erythrocyte 
containing lO^ug (closed circles), 2 5 ^ u g (open circles 
50yug (closed squares) and lOO^ug (open squares) ^Fe.
respectively, the rates of release of Fe between
one and four hours was virtually identical. At
four hours the mean percentages of radioactivity
(i SD mean) still present in the organs were
47(2 4)56 with the 10yug dose and 6o(i 6)$ with
100y u g ,  indicating that 36$ and 34$ respectively
had been released. Although the amounts of
radioactivity released were similar, the quantity
of iron was naturally ten times as great with the
bigger dose. This was reflected by the serum
iron concentrations (Fig 2). One hour after
injecting the cells containing 10yug iron, the
mean serum iron concentration (i SD mean) was
127(i 10)yUg/lOO ml, and at four hours 152(i 19)
y U g / l O O  ml. The comparable figures after
injecting lOOyug iron were 207 (-t 1 3 )yug/100 ml
and 364(i 9)y U g / l O O  m l .  Intermediate values were
obtained with the 25yug and 50yug doses. No
significant differences were noted in the rates
of breakdown of labelled haemoglobin or in the
59percentages of Fe in ferritin with the different 
loads of labelled erythrocytes. After four hours 
between 12$ and 22$ was still present as haemoglobin, 
while 24 - 35$ was in ferritin.
b 5
EFFECTS OF HYPERTRANSFUSION AND OF VENESECTION.
Uptake and release were compared in 18 hyper-
transfused, 18 venesected and 2 k control rats
(Fig 3 ) . A third of the animals in each group
were killed one hour after injecting the labelled
denatured erythrocytes. At this time the mean
percentages of injected radioactivity present in
the combined,livers and spleens were virtually
identical in each group, but more was in the
spleens and less in the livers of both the
venesected and the polycythaemic rats than in the
normal animals (Table III). Half the remaining
rats from each group were killed at four hours.
59In all the animals the amount of Fe in the 
spleens had decreased, but the fall was greater 
in the venesected animals than in the other two 
groups, which were very similar. Radioiron 
had also been released from the livers of the 
normal and venesected rats, but the percentage 
in the livers of the hypertransfused animals 
had increased by 1 6 °t> which matched the fall in 
splenic activity almost exactly. The mean 
percentages of injected radioactivity present
LIVERS AND SPLEENS SPLEENS LIVERS
P1 ffure 3. ElTects of venesection and hypertrans- 
fusion upon the release of iron from hepatic and 
splenic reticulo-endothelial cells. Mean values 
(i SD mean) in normal (open circles), venesected 
(closed circles) and hypertransfused (open squares)
rats.
TABLE III
EFFECTS OF VENESECTION AND HYPERTRANSFUSION UPON DISTRIBUTION OF ^Fe AFTER INJECTING 
DENATURED ERYTHROCYTES CONTAINING (^Fe)-HAEMOGLOBIN
Hours after 
injecting 
labelled 
cells
Mean ‘fo Injected Radioiron (-SD) /Ug/lOOml
Liver & 
spleen
Ferritin Haemoglobin Liver Spleen Serum
Iron
UIBC
NORMAL 1 9 H ~ 3 ) 8(^2) 81(19) 47(A) 47(17) 205(i48) 232(i34)
4 6 2 ( ~ l l ) 35(is) i2(i4) • 32(i7) 30(i5) 2 0 3(i6 2) 1 3 6 (i5l)
2 k 5 o { U ) 30(^5) 6(12) 29(i4) • 2i(i5) 97(i2l) 28l(i20)
VENESECTED ' 1 96 (i 1) 3(-l) 90(i8) 36(±5) 6o(i4) 80(i2l) 29l(il7)
k 36(±7) 5(-l) 2 6(is) 10(i2) 26(i3) 97(il8) 2 9 1(i2 5)
2 k 13(-2) i(-o.5 ) 8(i3) 9(-2) 4(ii) 46(i7) 3 1 5 (i2 9)
HYPERTRANS FUSED 1 95(~5) 10(~2) 82(i5) 39(-5) 5 6 (i6 ) 2 3 1(i4o) 5l(ll3)
k 93(-2) 6 2(1 2 ) io(i4) 55(^3) 38(i4) 2 3 6(i2 0) 34(i5)
2 k 8 8(-7 ) 6 5 (A) 4(i2) 5 6 (i8 ) 33(i5) 23l(i69) 5 6 (iio)
in the combined livers and spleens in the form 
of ferritin at four hours were markedly different 
in each group. Only a mean of 5$ was in this 
form in the venesected rats, compared with 62$ 
in the hypertransfused rats and 35$ in the 
controls. In the venesected animals a mean of 
26$ of the injected radioactivity was still 
present as haemoglobin, compared with only 10$ 
in the hypertransfused and 12$ in the control 
animals. After 2 b hours these figures were all 
below 10$, so that the differences between the 
four hour figures could not be ascribed to the 
presence of labelled reticulocytes in the liver 
and spleen.
After 2 b hours all the remaining animals 
were killed. At this time there had been 
virtually no further changes in the amounts of
59Fe present in the livers of all three groups.
In the spleens, on the other hand, there had been 
a considerable further decrease (22$) in the 
case of the venesected animals, and a smaller 
fall in the controls (9$) and in the hypertrans- 
fused animals (5$)• Almost none of the ^^Fe in
the combined livers and spleens was in the form 
of ferritin at this time in the venesected animals, 
compared with a mean of 65$ in the hypertransfused 
rats and in the controls.
EFFECTS OF PRIOR LOADING ¥ITII IRON IN VARIOUS FORMS.
Denatured erythrocytes.
Heat-ddnatured erythrocytes containing 100y u g
unlabelled iron as haemoglobin were injected
intravenously into six groups of 12 animals each
ngat various times up to 24 hours before the Re­
labelled cells. Half the animals in each group 
were killed after one hour and the remainder 
after four hours. The percentage of injected 
radioactivity present in the combined livers 
and spleens at one hour was not significantly 
altered by injecting the unlabelled cells before­
hand (Table IV), but the distribution between 
spleen and liver varied in the different groups.
In the control group a mean of 30/^  was in the 
spleen and 56°/° in the liver (Fig 4). The maximum 
deviation from this pattern was in the group 
given the unlabelled erythrocytes three hours
TABLE TV
EFFECT OF UNLAEELLED DENATURED ERYTHROCYTES INJECTED AT VARIOUS TIMES
BEFORE DENATURED ERYTHROCYTES CONTAINING (59Fe)-HAEMOGLOBIN
Timing of 
first in-
Hours after 
injecting
Mean $ Injected Radioiron (1 s d ) yUg/lOOml
jection before 
labelled cells 
injected
labelled
cells Liver & 
Spleen
Ferritin Haemo—
Globin
Liver Spleen Serum
Iron
UIBC
Control 1
4
8G±5
50-6
9i2
2 8 -9
7 6I1 0
1 4I3
56^3
32-5
3 0I6
18i4
217x32
2 8 6 -3 2
224I19
19lll4
Released 36 24 12
2 1
k
97-3
6 2 - 5
13^3
35-k
8 9ilO
I4i6
65^5
39-2
32^5
23-5
3 5 7I28
29819
46I3
8 8I9
Released 35 26 9
3 1
k
93±6
61-3
9^3
37-5
3 oil2
20I7
70^5
4ol4
2 3—8
2 1 - 3
3 1 8I34
3 2 7I30
6 5I20
I29I62
Released 32 30 2
6 X 1
4
9h±k
72.-3
9—2
k7 -k
85^5
1413
39x3
3 8I2
55^7
3414
229142
2 3 4I27
I8 3I22
19 0I16
Released 22 1 2 1
9 1
k
8 7-k
6 5-k
1 6 - 6  
43-5
6 6 - 6
ll-k
5 6 - 8
42^5
3 1 ^ 1 2
2 3Z3
134140
I43ll4
2 60I22
253^34
Released 22 l4 8
12 1
k
8 9X?
61-3
16^3
39-2
6 9 - 6
5-2
54i4 
38 ± 6
35^3
2 3I4
I48ll9
2 2 5I32
30 9I30
260I16
Released 28 16 12
24 i
4 96^35 6 16
1 3I4
35-8
77;10
6l4
6 6± 4 
35-8
3 0I2
2 1 - 6
1 5 2I36
1 9 4I34
315x41
239143
Released 4o 31 9
X The labelled erythrocytes in this group were obtained from a different rat
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Hours before labelled cells injected
Figure U. Effect of injecting unlabelled heat 
damaged erytlirocytes at various times before the 
labelled erythrocytes. Mean (~ SD mean) percentages
I j Oof injected Fe in the individual livers and spleens
one hour (closed circles) and four hours (open circles)
after injecting the denatured erythrocytes containing 
.tin(Fe)-haemoglobin. The shaded areas represent 
the release of radioiron from the two organs 
between one and four hour’s.
beforehand, splenic uptake being decreased to 
23/o and hepatic uptake increased to 70$>. However, 
in the groups given the unlabelled cells 9> 12 
and 2k hours beforehand, the pattern was approxi­
mately the same as in the controls. The mean 
serum iron concentration in the two-hour and 
tliree-hour groups were considerably higher than 
in the control animals, but in the 9—hour,
12-hour and 24-hour groups they were lower than 
in the controls.
In contrast to the situation at one hour, there
were marked differences between the percentages of
59injected ' Fe present in the combined livers and 
spleens of the different gx’oups at four hours. The 
maximum effect was seen in the groups given the 
unlabelled denatured erythrocytes six and nine 
hours beforehand: means of 7 2 fo and 6 5/& respectively 
were still present in the combined organs of 
these groups compared with 50 ‘fo in the control 
group. Between one and four hours axsproxlmately 
36% had therefore been released in the controls, 
compared with only 22‘fo in the groups given 
the unlabelled erythrocytes s ix and
nine liours beforehand. The inhibition of release
was not as marked if the interval between the 
unlabelled and the labelled cells was 12 hours, 
while in the 24-hour group the amount released 
was similar to that in the control group. The 
maximum inhibition of release from the liver and 
spleen individually did not occur in the same 
groups. Approximately 12$ was released from the 
spleens of the control group, and this figure 
was only 2$ in the group given the unlabelled 
cells three hours before the labelled cells.
In this group hepatic release was approximately 
30$, compared with 24$ in the control group,
Total release in the three-hour group was thus 
hardly altered. In the nine-hour group, on the 
other hand, hepatic release was 14$ and splenic 
8$ (Fig 4). In the six-hour group, "'’^ Fo-labelled 
erythrocytes from a different donor had to be 
used because not enough blood could be obtained 
from a single donor animal; although total 
release in this group appeared to be in line 
with the findings in the other groups, the 
distribution of labelled erythrocytes between 
liver and spleen was quite different, and it was
interesting to note that inhibition of release 
was much more marked in the liver than in the 
spleen. This suggested that the degree to which 
release was inhibited was influenced by the size 
of the load of denatured labelled cells in each 
organ.
The percentages of injected radioactivity 
present as ferritin in the organs of the animals 
killed after four hours followed an inverse pattern 
to that of total release. In the six- and nine- 
hour groups, mean percentages of h jfo and hyfo 
respectively were in this form, compared with 
28 fo in the control rats. The mean percentage 
still present as haemoglobin din the animals 
killed after 4 hours was lower in the 12-hour 
and 24-hour rats than in the control animals.
A second experiment was performed to
discover whether there was any relationship
between the extent to which the release of iron
was inhibited and the load of denatured labelled
erythrocytes. Two groups of 24 rats each were
studied, the first being given cells containing 
5915 yug • Fe as haemoglobin and the second 100 /Ug./L
Six hours beforehand, half the animals in each
group were given unlabelled denatured erythrocytes
containing 1 0 0  y u g  iron, while the remaining rats
received isotonic saline. Half the rats in each
of the four groups obtained in this way were
killed after one hour. The percentage of injected
radioactivity present in the combined livers and
spleens was lower in the animals given the 15 y u g  
«
dose of denatured labelled cells than in those 
given 100 yug (Table V), When the remaining 
animals were killed after four hours, however, 
it was apparent that release between one and 
four hours was remarkably similar in the two 
control groups. Release was inhibited in both 
groups which had been given the unlabelled cells 
six hours before the labelled cells; however, the 
inhibition was greater in the rats given the 15 yug
dose of labelled cells (2yfo) than in those given 
the 100 y u g  dose (1 3$). The percentage in ferritin 
was also greater, and in both groups was greater 
than in the respective control groups. Splenic 
release was inhibited to a greater extent than
hepatic release.
INHIBITION OF 59Pe RELEASE BY UNLABELLED DENATURED ERYTHROCYTES INJECTED 6 HOURS BEFORE 
DENATURED ERYTHROCYTES CONTAINING (^Fe)-HAEMOGLOBIN.
EFFECT OF VARYING THE LOAD OF LABELLED ERYTHROCYTES.
Quantity of Haemoglobin 
iron in labelled cells
Nature of injection 
6 hours prior to 
labelled cells
Hour's after 
injecting 
labelled cells
Mean jo Injected Radioiron (ISD)
Liver & 
spleen
Ferritin Liver Spleen
Saline 1
4
80(±3) 
39(-5)
12(14)
20(14)
U(i6)
22(t3)
39(1.2) 
17(14)
15 yug Released 4l 19 22
Unlabelled
denatured
cells
1
4
84(±2)
66(14)
13(±2)
« ( i 3)
54(13)
42(13)
30(±3)
24(12)
Released 18 12 6
Saline 1
4
98(-3) 
57(-6)
5(11 ) 
20(12)
46(14) 
28(15)
52(13)
29(13)
Released 4l 18 23
100 y U g Unlabelled
denatured
cells
1
4
96(i3) 
68(15)
9(ii)
34(17)
45(15)
29(15)
5l(l3)
39(15)
Released 28 16 12
A final experiment was undertaken to 
determine whether the enhanced iron release in 
venesected rats could be inhibited by the injection 
of unlabelled denatured erythrocytes six hours 
previously. Twelve venesected and 12 normal 
rats were used (Table Vi) . Approximately 3 h% 
was released in the normal rats compared with 
53% in the venesected animals. In the animals 
given the unlabelled denatured erythrocytes 6 
hours beforehand, release was reduced to 9% and 
2 6% respectively. Splenic and hepatic release 
were inhibited to approximately the same extent.
NTA-Iron
Unlabelled NTA—iron in a dosage of lOOyUg 
was injected intravenously into groups of eight 
rats at the same times as previously, and the 
same procedure was followed. The mean percentage 
of injected radioactivity present in the combined 
livers and spleens again varied only slightly, 
but the distribution of the labelled erythrocytes 
between the two organs was altered, on this 
occasion in the opposite direction to the previous 
experiment (Ta.ble VII) . In the control group
INHIBITION 
DENATURED 
EFFECT ON
OF "^Fe RELEASE BY UNLABELLED DENATURED ERYTHROCYTES INJECTED 6 HOURS BEFORE 
ERYTHROCYTES CONTAINING (^Fe)—HAEMOGLOBIN:
NORMAL AND VENESECTED RATS
Mean(range)^ Injected Radioiron
Nature of injection Hours after Liver Liver Spleen 
6 hours prior to injecting & 
labelled cells labelled cells spleen
saline 1 8 6(85-8 9) 3 6 (29-4 4) 50(42-58)
4 33(30-38) io( 9-1 2) 2 3(21-2 7)
Venesected Released 53 26 37
Unlabelled 1 7 2 (69-7 8) 2 7 (20-3 5) 45(30-49)
Denatured cells 4 46(45-49) 1 8 (1 7-1 9) 2 8(26-3 0)
Released 26 9 17
saline 1 7 8 (65-8 5) 41(35-48) 37(29-49)
4 44(38-48) 2 1 (1 3-2 6) 2 3 (22-2 5)
Released 34 20 14
Normal Unlabelled 1 8 0(7 7-8 8) 35(24-40) 45(40-48)
Denatured cells 4 7 1 (6 7-7 6) 2 8(26-3 2) 4 3 (3 5-4 9)
Released. 9 7 2
Ox
00
TABLE VII
EFFECT OF 100 /ug NTA—IRON INJECTED AT VARIOUS TIMES BEFORE DENATURED ERYTHROCYTES 
CONTAINING (5^Fe)-HAEM0GL0BIN
Timing of 
first in­
jection - 
hours before 
labelled 
cells injected
Mean $ Injected Radioiron (-SD) /Ug/lOOml
IIuujl s af Lex
injecting
labelled
cells
Liver
&
spleen
Ferritin Haemo­
globin
Liver Spleen Serum
Iron
UIBC
CONTROL 1
4 % ® J ® % ®
181i
2501fifo j
2901
1651
Released 3 6 15 21
2 1
4 n m i t ®
63(^7)
hk\t7)
3001
2271|3?>
1591
1931!% !>
Released 2 0 1 19
3 i
4
95(^3) 
8*i (±4)
1 6 (i2 ) 
k9(-3) 2 ( !§ i
39(iM
33(-3) l l ®
2991
2191
1211
2181
Released 11 6 5
6 1
4 9 M | 6)81(^2)
2l(l4)
k8(—2) 2IH }> 11® i m 1441 1491® ) 26012711: i 8 l
Released 13 3 10
9 1f,4
92(ii) 
7 0 ( - 6 ) 11® l l ® a ® ! 35(±7)27(-9) 124|1821 305 ( 272 (
Released 22 1 3 8
12 1
4 m S i i ’ j
1 5 0 (
193(■ m
2 6 3<
233(m
Released 27 11 13
1 94(13) 66(i!3) 50(15) 44(14)
26(15)
165(118) 267(119)
k 55(15) 11(12) 29(13) 244(129) 209(129)
Released 39 21 18
the radioactivity was distributed approximately 
equally between the two organs, whereas in the 
previous experiment there was almost twice as 
much in the liver as in the spleen. The serum 
iron concentrations were once again markedly 
elevated in the two—hour and three-hour groups, 
and depressed in the six-, nine- and twelve-hour 
groups.
At four hours there was more radioiron 
still present in the combined livers and spleens 
of all the groups given NTA-iron beforehand than 
in the control group, the only exception being 
the 24-hour group. The maximum inhibition of 
release was in the three-hour and six—hour groups 
(Fig 5). Hepatic release was virtually zero 
in the two-hour group, splenic release being 
unaltered at this time. In the other groups, 
however, release was inhibited to an approximately 
equal extent in each organ (Fig 6).
As in the previous experiment, the mean 
percentage of injected radioactivity present as 
ferritin in the animals killed after four hours
HOURS BEFORE LAB ELLED  CELLS INJECTED
Figure 5. Effect of injecting 100 yug NTA-iron at
various times before the denatured labelled
erythrocytes. Mean (i SD mean) percentages of
59injected Fo in the combined .Livers and spleens
one hour (closed circles) .and four hours (open
circles) after injecting the denatured erythrocytes
/ 59 \containing ( Fe)-haemoglobin. The shaded area 
represents the release of radioiron between one
and four hours
Hours before labelled cells injected
Figure 6. Effect of injecting 100yug NTA-iron
at various times before the labelled erythrocytes.
Mean (-SD mean) percentages of injected Fe in the
individual livers and spleens one hour (closed
circles) and four hours (open circles) after injecting
/59 \the denatured erythrocytes containing ( Fe;~ 
haemoglobin. The shaded areas represent the release 
of radioiron from the two organs between one and
four hours
was greatest in those groups in which total 
release was maximally depressed (Fig 7)« In this 
experiment, however, the percentage present as 
haemoglobin din the animals killed after four 
hours did not vary significantly.
A further experiment was then performed in 
which the amount of NTA-iron was reduced, so that 
most or all'of it would be taken up by unsaturated 
transferrin. Initial experiments using rats 
weighing 300 g established that 35yug iron as 
NTA-iron increased the serum iron concentration 
to a mean of 3^6^,ug/l00 ml (UIBC 59 ^ug/lOO ml) ; 
one hour later the serum iron had fallen to a 
mean of 278 yug/l00 ml, and a second injection 
of 12 ^ug iron as NTA-iron at this time raised 
it to a mean of 366 ^ug/lOO ml. After a further 
hour this figure was 304 ^ug/lOO ml. By labelling
59with Fe, it was established that the distribution 
of the 35 yug NTA-iron in the blood and organs 
was the same as that of tracer amounts of radioiron 
incubated with rat plasma before injection, 
suggesting that all the injected NTA-iron had been 
bound by transferrin. In contrast, when 100 ^ug
6 k
HOURS BEFORE LABELLED CELLS INJECTED
Figure 7« Effect of injecting lOO^ug NTA-iron
at various times before the denatured labelled
59erythrocytes on the percentage of injected Fe 
released from reticulo-endothelial cells (open 
circles) and present in ferritin (closed circles) 
four hours after injecting the denatured labelled 
erythrocytes. Closed squares, serum iron concen­
trations one hour after injecting the denatured 
labelled erythrocytes.
TABLE VIII
THE DISTRIBUTION OF RADIOIRON AFTER INJECTING 59Fe BOUND TO 
TRANSFERRIN AND TO VARYING AMOUNTS OF NTA 59Fe
Mean(range)^ Injected Radioactivity
Organ
100yUg 
NTA 59Fe
35yUg
NTA 59Fe 59Fe Transferrin
Liver 3 1 .0 (2 6.3-3 4.l)X 6.7 (6 .2-7.1) 9.0 (8 .1-1 0.3 )
Spleen 1 .1 (0.9-1 .3 ) ' 0.4(0.35-0.45) 0.4 (0. 3-O.5 )
G. I.T. 9.1 (7 . **-10.5) 6 .5(5.4-7.6) 3 .8 (3 .6-4.9)
Kidney 4.8(4.5-5.1) 3 .8 (3 .6-4 .0) 1 .9 (1 .6-2.3 )
Heart 1 .3 (0.7-2.3 ) 1 .2 (1 . 0-1 .5 ) 1 .3 (0.5-1 .5 )
Lung 1 .9 (1 .4-2.7 ) 2 .l(l.9-2.4) 2, 9 (2.0-4.1 )
Blood 1 2 .8 (6 .6-1 6.8 ) 42.5(41.0-44.3) 46.0(43.2-49.1)
Carcass 52.6(48.4-54.9) 2 9.0 (2 7.0-3 1.8 ) 2 2.0(2 1,2-2 2.7 )
Serum Iron 
( yU-g/lOOffll)
361(340-391) 3 4 6(3 2 1-3 6 3) 1 8 0(1 7 0-1 8 1)
X3 animals/group, killed 15 minutes after tb.e radioiron
injection.
NTA~±ron labelled with Fe was injected, an 
increased percentage of radioactivity was located 
in the liver (Table VIIl).
Sixteen rats were given injections of 35 y U g  
and 12 yug NTA—iron six and five hours respectively
59,before the denatured Fe-labelled erythrocytes, 
while a further 12 received isotonic saline.
Half the animals in each group were killed at 
one hour and the remainder at four hours (Table IX). 
At one hour the mean percentages (i SD mean) of 
injected radioactivity present in the livers and 
spleens were 98 (i 2)^ and 96 (i 3)$> in the NTA- 
iron and control groups respectively. At four 
hours significantly less radioiron had been 
released from the NTA-iron group, the mean 
percentage (i SD mean) still present in the two 
organs being 68 (i 6)^ compared with 59 (± l ) 1o ±a 
the control rats (t.^, 2 .6 9; P<T.02).
A striking feature of the results of experiment
in which denatured erythrocytes or NTA—iron were 
given prior to the labelled denatured red cells, 
was the association between impaired release of
labelled colls and an increased percentage of
INHIBITION OP RELEASE BY NTA—IRON: 35yUg INJECTED 6 HOURS AND 12y i ig INJECTED 5 HOURS
BEFORE DENATURED ERYTHROCYTES CONTAINING (^Fe)-HAEMOGLOBIN
Nature of' injections 
6 and 5 hours prior 
to labelled cells
Hours alter 
in jecting 
labelled 
cells
Mean $ Injected Radioiron (1s d )x /ug/l00ml
Liver & 
spleen
Ferritin Liver Spleen S.I. UIBC
35 /ug NTA-Iron- 
6 Hours»
12 /ag NTA—Iron— 
5 hours
1
4
98(i2) 
68(16)
10(^3)
4i(i2)
. 42(is) 
30(12)
56 08) 
38(iS)
189(129)
268(148)
252(174)
157(167)
Released 30 12 18
Saline - 6 hours 1 96(±3) 7 (~3) 40(^7) 56(18) 219(125) 209(164)
Saline - 5 hours 4 59(-7) 3 2 (±6 ) 26(13) 33(16) 277(130) 188(168)
Released 37 i4 23
X6 animals/group - controls; 8 animals/group - experimental
c\
labelled ferritin in the liver and spleen. It was 
therefore decided to examine the effects of 
inhibiting ferritin synthesis on reticulo­
endothelial release. Such an inhibition has 
previously been achieved using cycloheximide 
(Chu & Fineberg, 1 9 6 9), and preliminary studies 
were therefore carried out to establish the best 
time for administering it. It was found that 
cycloheximide in a dose of 200 mg intramuscularly 
inhibited the uptake of denatured labelled
erythrocytes by the liver and spleen, haemoglobin
59catabolism and the release of Fe, unless it 
was injected at least 15 hours before the 
erythrocytes (Table X). This time interval 
was therefore selected for an experiment to 
determine whether inhibiting ferritin synthesis 
would abolish the effect of a previous injection 
of iron.
Twelve rats were given cycloheximide and 
2 ’l isotonic saline (Table Xl) . Nine hours later 
the cycloheximide group and half the saline group 
were given 100 j w g NTA-iron intravenously, while 
the remaining rats were given a second injection
TABLE X
EFFECT OF 2 0 0 y U g  CYCLOHEXIMIDE INJECTED INTRAMUSCULARLY AT 
VARIOUS TIMES BEFORE DENATURED ERYTHROCYTES CONTAINING 
(^Fe ) —HAEMOGLOBIN
Mean $ Injected Radioiron
Hours Injection
before before Liver & Spleen Ferritin Haemoglobin
labelled labelled
cells cells 1 hour 4 hours Rel. 4 hours 4 hours
1X cycloheximide 43 73 •-« 20 35
(35-50) (7 0-7 9 ) (17-21) (30-41)
91 62 23 16
saline (8 7-9 4) (5 5-6 9) 29 (18-25) (12-18)
6X cycloheximide 79 72 7 38 25
(74-8 3) (6 5-7 8 ) (32-42) (14-35)
90 51 27 14
saline (85-9 2) (4 7-5 5) 39 (23-30) (10-18)
10+ cycloheximide 85(—8) 6 5(h) 20 —
saline 9 2(i4) 5 4 (h) 38 - -
15+ cycloheximide 97(-2) 5M±6) 43 — -
saline 9 ’* (h) 46 d ) 48 - -
2 b + cycloheximide 9 0(h) 50(^3) 4o - -
saline 9 b ( 5) 5 0 ( 6) 44 - -
X - 4 animals/group - range in parenthesis: + 6 animals/group -
SD in parenthesis.
rel released
INHIBITION OP 59Pe RELEASE BY 100yug NTA—IRON INJECTED 6 HOURS BEFORE DENATURED CELLS
C ONTAINING (^Pe ) —HAEMOGLOBIN :
EFFECT OF 200yug CYCLOHEXIMIDE INJECTED INTRAMUSCULARLY 9HOURS BEFORE THE NTA—IRON
Nature of
injection
15 hours
before
labelled
cells
Nature of
Hours 
after 
injecting 
labelled 
cells
Mean $ Injected Radioiron (isD)
—LI J UO O _JL CJI1
9 hours 
before 
labelled 
cells
Liver & 
spleen
Ferritin Haemo­
globin
Liver Spleen
200 /Ug 
cydohex— 
im id s 
i.ffi.
1 0 0  /Ug
NTA—Iron
1
4
9 2(^8)
68(i6)
8(^2)
28(^2)
64(i6)
18(i3)
38(i6) 
28(^3)
53(—7) 
4o(i7)
Released 24 1 0 13
saline 1 0 0  yllg 1 9l(-3) 8 (-3) 66(i6) 39(-2) 52(14)
i. in. NTA—Iron 4 64(±5) 29(-4) 17 (-5). 27 (i6). .37 C-^)
Released 27 12 ' 15
saline saline 1 93 (± 4) 5 (-2) 82(^5) 39(~6) 54(A)
i. m. 4 59(~*0 29(~3) 1 6 (A) 23 (-4,) 36(A)
Released 34 16 18
of isotonic saline. After a further six hours 
all the animals received denatured labelled 
erythrocytes. Release was inhibited to the same 
extent in the rats given NTA-iron alone (7 )^ and 
NTA-iron plus cycloheximide (lO^ o) , and the 
percentages of injected radioiron present in 
ferritin were also virtually identical (28% and 
29^ respectively).
Ferritin
59Px’eliminary experiments with Fe-labelled 
ferritin revealed that it was rajoidly and completely 
taken up by the liver after intravenous injection 
(See chapter 4). Rat liver ferritin containing 100/ug 
ixnon was injected intx’avenously into 12 normal rats, 
while a fxxrther 12 received injections of isotonic 
saline. Six hours later heat-denatured isotopically 
labelled rat erythrocytes were .injected, and after 
a further hour half the animals in each group 
were killed (To.ble XIl) . The mean percentages of 
injected radioactivity (isD mean) present in the 
combined livers and spleens were 9^  (~ i° in the 
control rats and 93(~ 2)4, in those given ferritin.
The remaining rats were killed, at 3 hours, when a
EFFECT ON THE DISTRIBUTION OF RADIOIRON OF lOOyug FERRITIN INJECTED 6 HOURS BEFORE 
DENATURED ERYTHROCYTES CONTAINING (^ ^Fe)-HAEMOGLOBIN
Nature of Hours after + XMean Injected Radioiron (-SD) /Ug/l00ml
J_Jli J U O -J— Uli U iiU U.1 D
prior to labelled 
cells
labelled cells Liver & 
spleen
Ferritin Haemo­
globin
Liver Spleen S.I. UIBC
100yug 1 93(-2) 4(ii) 86(12) 3 9 ( - 5 ) 54(i5) 1 5 6(il9) 334(150)
Ferritin 3 56(16) 28(14) ' 15(^2) 24(^3) 32(i4) 2 2 0(^5 2) 250(160)
Released 37 15 22
Saline 1 9 k ( ± k ) .4(-2) 86 ( ± 7 ) 4o(±4) 54(15) 197(-18) 216(124)
3 5.2(13) 2 3(1 7 ) 1 6 (15) 2 4(1 5 ) 28(13) 271(144) 288(142)
Released 42 16 26
6 animals/group.
mean (i SD mean) of 52 (i 3)i° was in the livers 
and spleens of the control group, 23 (- 7 )f° as 
ferritin, compared with 56  ( -  6)^0 and 28 (i h ) cfo 
in the animals given ferritin.
EFFECT OF GIVING NTA-IRON AFTER THE LABELLED NON- 
VIABLE RED CELLS.
In two further experiments the effects of
giving NTA—iron after the labelled red cells were
studied. In the first, 11 rats were given 100 yug
59NTA-iron intravenously 30 minutes after the Re­
labelled denatured erythrocytes, while 11 control 
rats received isotonic saline (Table XIIl).
Four animals from each group were killed one hour 
after the injection of the labelled cells, at 
which time the mean(range) percentages in the livers 
and spleens were 9 2(90-9‘l)/° an-8 87(84-93) <f° 
respectively. After 2-| hours four further 
rats from each group were killed, when the 
mean figures (range) w e r e 82(79-8 6)^0 and 59 (56- 
6 h)$>. Release from the spleens was inhibited 
to approximately the same extent as the livers.
The remaining animals were killed at four hours, 
the mean percentages at this time were 6 7 (58-73)/£
EFFECT OF lOOyUg NTA— IRON INJECTED 30 MINUTES AFTER DENATURED ERYTHROCYTES CONTAINING (^Fe) -HAEMOGLOBIN
Nature of' 
injection after 
labelled cells
Hours after 
injection of 
labelled cells
Mean (range )$> Injected Radioiron yug/lOOml
Liver & 
spleen
Ferritin Liver Spleen UIBC
100 g
NT A~ Iren
1
21
92(90-94)
82(79-86)
7(4-11)
24(12-38)
42(35-50)
38(37-39)
50(44-55)
44(41-47)
30(23-44)
,108(48-148)
Released 10 6 4
4 67(58-73) 39(32-45) 35(32-40) 3 2 (26-3 6) 1 3 2 (1 2 3-1 3 8)
Released 2-|--4 15 .3 12
1
2-1-
87(84-93)
59(56-64)
8 (6-1 0)
1 5 (1 1-2 1)
4 1 (32-4 9)
2 6(22-3 1)
46(35-51)
3 3 (28-4 1)
234(230-238)
1 8 7(1 7 6-1 9 2)
Saline Released 28 15 13
4 53(50-56) 2 7(22-3 2) 2 6(2 3-2 9) 2 7(2 1-3 5) 2 0 0(1 8 1-2 1 2)
Released 2-4-4 6 0 6
and 53(50-5 6)#.
In a second experiment 20 rats were given 
denatured labelled erythrocytes containing 100yug 
iron and 10^ /ug iron (Table XIV). Release was 
inhibited by NTA-iron in the group receiving the 
larger load of red cells (approximately 1 5$ 
compared with 25$ in the controls), but not in 
those given«the smaller amount (24$ and 21$ 
respectively).
EFFECT OF INJECTING HUMAN TRANSFERRIN.
Initial studies were performed to test the efficacy
of using iron free human transferrin (Behringwerke
AG, Marburg-Lahn, Germany) in rats. The rate of 
r>9clearance of Fe bound to human transferrin and 
to rat serum was determined in groups of 3 rats.
The mean(range) half-disappearance time was similar 
in the two groups, values being 90(87-93) minutes 
and 92(86-94) minutes, respectively. Studies wore 
then performed to investigate the effect of increased 
available transferrin on reticulo-endothelial 
radioiron release in normal, venesected and hyper- 
transfused animals.
INHIBITION- OP 59Fe RELEASE BY lOO^ug NTA-IRON INJECTED 30 MINUTES AFTER DENATURED ERYTHROCYTES
CONTAINING (59Pe)-HAEMOGLOBIN :
EFFECT OF VARYING THE LOAD OF LABELLED ERYTHROCYTES
Quantity of 
Haemoglob in
I.v. injection
given
Hours 
after 
in jecting 
labelled 
cells
Mean ^ Injected Radioiron (1SD) /Ug./lOOmlXj. Ui.1 .i 11
labelled cells after tiie 
labelled cells
Liver < 
spleen
Sz Ferritin Haemo­
globin
Liver Spleen S.I. UIBC
NTA-
Iron
1
4
81(±3) 
57(-9)
19(16) 
50(ll4)
5 9 ( - 1 0 )
i u ( i h )
58(14) 
3 0 (I2)
23(^4) 
27(I9)
556(135)
351(133)
25(I2) 
199(164)
10 j Vl g Released 2 b 28 -
saline I
4
80(i4)
5 9 ( - h
I4(ll)
37(1^)
6 6 (ii2) 
7 (-3)
47(13)
32(14)
3 3 (—3 )
27(-3)
1 6 1 (1 2 0)
243(132)
337(135)
288(158)
Released 21 15 6
NTA—
Iron
1
4
97(-6)
82(15)
5(-l)
44(lll)
95(13) 
27(14)
45(17)
40(15)
52(18)
42(14)
470(141)
516(181)
39(18) 
44(ll9)
100 yVLg Released 15 5 10
saline 1
b
93(13) 
68 (13)
7 ( - 2 )  
35 O'*)
84( Is )
30(12)
4 9(lio) 
3 1 (1 3 )
44(li2) 
37(14)
314(172)
408(131)
247(186)
3l(ll4)
Released 25 18 7
In the first experiment groups of 10 x'ats
were killed 1 and 4 hours after an injection of
denatured erythrocytes containing ('^Fe)-haemoglobin.
Half the animals received human transferrin
intravenously rJ>0 minutes after the erythrocytes,
while the remainder received saline (Table XV), The
release of radioiron was similar in the animals
who received transferrin and in the controls «
(40*0 and 44^ o, respectively). The plasma iron 
concentrations were, however, higher at 4 houi’s in the 
rats given human transferrin than in the control animals. 
This suggested that additional iron had been taken up 
from a source other than reticulo-endothclial cells.
Studies were then performed on venesected rats.
The dose of transferrin and the load of labelled 
cells injected was varied, but no effect on reticulo­
endothelial radioiron release was noted (Table XVI),
In all the studies, the plasma iron concentrations at 4 
hours were higher in the animals who received transferrin,
In a final study lOOmg human transferrin in divided 
doses administered to 6 hyper transfused .rats, the first 
injection being together with and the second 30 minutes
EFFECT OF 50mg HUMAN TRANSFERRIN INJECTED 30 MINUTES AFTER DENATURED ERYTHROCYTES CONTAINING 
(2 9pe)-HAEMOGLOBIN
Mean 'fo Injected Radioiron (isD) /ug/lOOml
mature 01 injection 
30 minutes
alter labelled cells
Hours alter
labelled
cells
Liver & 
spleen
Ferritin Haemo­
globin
Liver Spleen Serum
Iron
UIBC
50m g
Transferrin
1
4
9 0(±i)
5 0 ( - k )
Mil)
23(^5)
88(±4)
I4(i3)
36(^3) 
22(—l)
54(15) 
28(14)
195(il6)
334(ill)
425(-36)
357(^22)
Released b o 14 26
Saline
1
4
9l(-5) 
47(±6)
Mil)
I8(i6)
83(15)
1 6 (1 2 )
46(ll)
21(13)
45(15) 
26 (15)
I59(i2l)
2 3 6(±3 0)
2 9 6(1 3 1 )
I89(i33)
Released b b 25 19
I RJMAN TRANSFERRIN 
EFFECT OF VARYING
INJECTED INTO VENESECTED RATS: 
THE LOAD OF TRANSFERRIN AND OF DENATURED ERYTHROCYTES CONTAINING ( ^Fe ) -HAEMOGLOBIN
Quantity of 
haemoglobin 
iron in labelled 
cells
Nature of Injec­
tion 30 minutes
after
labelled cells
Hours
after
labelled
cells
Mean^ Injected Radioiron(iSD)^ /Ug/l00ml
Liver & 
spleen
Liver Spleen Serum
Iron
UIBC
50mg
transferrin
1
4
9 5 (-3) 
46(±6)
38(i5)
2l(-4)
57(-2) 
25(i6)
208(il6) 
5 4o(i7 4 )
427(i37)
2 8 6(i5l)
100yug Released 49 17 32
saline
1
4
9 5(h)
« ( L )
46(ii) 
47(-3)
49 ( - 5 ) 
29(-5)
258(i50)
46o(i3 8)
2 2 0(i6 9)
85(i24)
Released 4 9 19 30
10 yUg
50mg
transferrin 1 83(-3) 48(ill) 35(ill) 241(i86) 447(i44)
saline 1 84(i6) 49(i9) 35(is) 2 2 6(i7 2) 2 5 0(i8l)
150 y U g
lOOmg
transferrin
1
4
79(-9)
79(-7)
24(i9) 
2 3(ii2)
5 5 (A)
5 6 (h)
I99(i56)
584(i67)
780(il33)
195(im)
saline
1
4
6i(iio)
84(il2)
2i(i7)
30(i4)
4o(i7)
5^(il2)
5l(i6)
354(i46)
3 1 7 (i42) 
7l(i30)
\r animals/group
<1vo
after tlie injection of denatured erythrocytes containing 
( Fe)-haemoglobin. A further 6 animals received 
saline instead of transferrin. At one hour a mean 
(range) of 97(96-98)$ of injected radioiron was in 
the livers and spleens of the animals that received 
transferrin compared with 94(91-96)$ in the 
controls. At 4 hours the values were 89(85-94)$ 
and 91(86-97)$’ respectively. Once again 
enhancement of release was not noted.
EFFECT OF A TURPENTINE ABSCESS.
Twelve rats were given intramuscular injec­
tions of 0,2 ml mineral turpentine 20 hours 
before the denatured labelled erythrocytes, while 
twelve control rats received injections of 
isotonic saline. At one hour a mean (i SD mean) 
of 94(i 5)$ of the injected radioiron was in the 
livers and spleens of the control animals, 
compared with 99(~ 5)$ in the turpentine group.
At four hours these figures were 53(~ 5)$ and 
65(i 8)$ respectively (t^©* 3«49; P<0.0l), indicat­
ing that appx’oximately 4l$ and 34$ had been released.
The inhibition of release in the turpentine 
group was reflected in the mean serum iron
concentrations; at one hour the figure (i SD mean) 
was 104(i 7 )yUg/lOO ml compared with 2 h h ( ~  3 3 ) y u g/
100 ml in the control rats, and at four hours
131(- 2 6)yug/l00 ml compared with 2 9 8(i 12)yug/lOO ml.
The radioiron which had not been released was
present as ferritin, since a mean SD mean)
of 42(i 3)1o was in this form in the turpentine
group at b hours compared with 3 0(~ 3)% in the
controls. The percentages still present as
haemoglobin were very similar, namely 10(i 1 )<f0
and ll(i 2)%.
DISCUSSION
The initial experiments using normal rats
confirmed the observations of Noyes et al (i9 6 0)
that not all the radioiron liberated from
catabolized haemoglobin enters the plasma when
the load of denatured erythrocytes is unphysio-
logical. The maximum release occurred between 
«one and four hours after injecting the denatured 
cells, and the superfluous radioiron was stored. 
It was noteworthy that similar percentages of 
erythrocyte radioiron were released in the face 
of a tenfold variation in the load of denatured 
cells. At least under these experimental 
conditions, therefore, a tenfold increase in the 
rate of red cell breakdown resulted in a 
proportional increase in the rate of delivery 
of iron to the plasma even though the requirement 
for erythropoiesis was unaltered, and this was 
reflected by a considerable rise in the serum 
iron concentration.
If the load of denatured cells was kept 
constant, the amount of labelled haemoglobin 
iron released into the plasma could be altered
by manipulating the rate of erythropoiesis.
Release was enhanced if the marrow had been 
stimulated by previous venesections, but the 
situation in the animals in which erythropoiesis 
had been inhibited by hypertransfusion was less 
clear. When the liver and spleen were considered 
together, there appeared to have been marked 
inhibition of release, but in fact radioiron 
had been released from the spleen to approxi­
mately the same extent as in the normal animals, 
and this had been balanced by a reciprocal 
increase in the amount of radioiron in the liver. 
The rise in hepatic radioactivity may have been 
partly due to the uptake of radioiron from the 
plasma by liver parenchymal cells, since this 
would be facilitated by saturation or near 
saturation of the transferrin entering the liver 
from the splenic vein. However, the fact that 
hepatic uptake was rapid and complete suggests 
that the radioiron released from the spleen was 
present in some other form. Whatever the 
explanation, it appeared that there was a 
difference in the behaviour of hepatic and splenic
reticulo-end.othe3.ial col3.s.
In further experiments it was possible to
show that certain other manoeuvres inhibited the 
release of radioiron from both liver and spleen. 
Inhibition was produced by transfusing unlabelled 
erythrocytes which had been denatured by heating 
in the same way as the labelled cells. An 
intravenous injection of NTA-iron had a similar 
effect, but in this case the maximum depression 
was observed with a somewhat shorter time interval 
between the two injections. Iron chelated by 
nitrilo-triacetic acid is very rapidly given up 
to transferrin (hates et al, 1 9 6 7). Since 
release was inhibited when the amount of NTA-iron 
was small enough not to exceed the binding 
capacity of the plasma, it seems reasonable to 
suppose that the rise in serum iron concentration 
(or the fall in unsaturated iron banding capacity) 
was the effective stimulus. This could also 
have been the trigger in the case of the uulabelled 
denatured erythrocytes, since the quantity of 
haemoglobin iron in the cells was sufficient to 
produce a significant elevation in the serum iron 
concentration (Table IV). The time necessary for 
liberation of the iron from haemoglobin before its
release into the plasma might explain the slightly 
longer interval between the two injections 
needed for maximum inhibition. Injecting ferritin 
intravenously did not alter either the serum 
iron concentration or the pattern of release.
If an elevation in the serum iron concentra­
tion does indeed directly alter the behaviour 
of reticuloj-endothelial cells,, so that after a 
few hours a smaller proportion of haemoglobin 
iron is released into the plasma, a fall in the 
serum iron concentration might have the opposite 
effect. There is a temporary decrease in the 
serum iron concentration when erythropoiesis is 
stimulated by venesection or by a reduction in 
atmospheric pressure, and this could be the 
stimulus to increased iron release. However, 
it was not found possible to devise manoeuvres 
which reduced the serum iron concentration 
without at the same time altering the rate of 
erythropoiesis. Injecting iron-free human 
transferrin increased the unsaturated iron 
binding capacity, but the release of radioiron 
was not enhanced. In all these experiments the
serum iron concentration rose following the 
injection of the transferrin, suggesting that 
there had been an increase in the release of 
unlabelled iron; the source of this iron was 
not, however, elucidated. While this suggested 
that the human transferrin was exerting a 
physiological effect, it still remains possible 
that it was not acting as effectively as rat 
transferrin would have done.
Consideration must be given not only to the 
stimulus which initiates the change in the pattern 
of release, but also to the mechanism by which it 
is brought about. The iron which is freed from 
catabolized haemoglobin follows one of two 
possible pathways. Either it is released within 
a few hours into the plasma, or else it is 
incorporated into storage compounds in the 
reticulo—endothelial system. Nothing is known 
about the chemical form of the iron after it has 
been freed from porphyrin; it does, however, 
seem reasonable to postulate that there is a 
common pool from which the iron enters either 
the plasma or the storage complexes. If entry
into the plasma is delayed because the supply of 
transferrin binding sites for iron is reduced, 
this pool would tend to enlarge. Evidence that 
increasing the percentage saturation of plasma 
transferrin does delay the release of iron into 
the plasma was provided by the experiments in 
which NTA-iron was injected 30 minutes after 
the denatured labelled erythrocytes. The fact 
that the release of iron from a small load of 
labelled erythrocytes was not inhibited by this 
manoeuvre is compatible with this hypothesis, 
since a shortage of free transferrin binding 
sites would be expected to have a more marked 
effect when the amount of iron awaiting release 
was large. An increase in the size of the common 
pool would make more iron available for incorpora" 
tion into storage compounds. It has been shown 
that iron stimulates ferritin synthesis, and it 
is of some interest that the maximum effect 
occurs 5 hours after injecting the iron (Drysdale 
and Munro, 19 6 6), the time interval found to be 
necessary to produce maximum depression of 
release by NTA-iron. It is therefore suggested 
that induction of ferritin synthesis by enlargement
of the "pre-release” Iron pool is the mechanism 
which diverts iron into the stores. Some support 
for this hypothesis is provided by the demonstration 
that more radioiron was present in ferritin in all 
the experimental situations in which release was 
inhibited. Furthermore, the fact that the 
inhibition following the injection of unlabelled 
cells was more marked when the load of labelled 
erythrocytes was small (Table V) is consistent 
with an increased capacity of the ferritin 
synthetic pathway. An attempt was made to test 
this hypothesis directly by using cycloheximide 
to inhibit ferritin synthesis (Chu & Fineberg,
1 9 6 9), hut this was inconclusive since neither 
the inhibition of release nor the incorporation 
of radioiron into ferritin was altered. Presumably 
the radioiron was taken \ip by the preformed 
ferritin since ferritin synthesis is known to 
be almost totally impaired under these experimental 
conditions (Goldberg, 1970)•
While stimulation of ferritin synthesis by 
the accumulation of iron seems the strongest 
possibility at the present time, other mechanisms
by which alterations in release might be effected 
must also be considered. When release was 
stimulated by venesection, the rate of catabolism 
of haemoglobin was slowed (Table III), and it 
seemed possible that if iron were entering the 
"pre—release pool" more slowly, the pool might 
be smaller, and this might be the reason why 
less iron was deviated into stores. The finding 
that the liberation of radioiron from haemoglobin 
was possibly faster at the time of maximum 
depression of release following the transfusion 
of unlabelled denatured cells (Table IV) was 
consistent with this idea. However, no change in 
the rate of haemoglobin catabolism was detected 
in the experiments with NTA-iron (Table VIl), 
although the inhibition of release was more 
marked, and it was also not apparent in the 
turpentine experiment. It therefore appears 
that while the rate of breakdown of haemoglobin 
probably does vary, this is unlikely to exert 
a direct influence on the proportion of radioiron 
released.
Several of the manoeuvres producing a change
in the amount of haemoglobin iron released onto 
the plasma also altered the distribution of the 
denatured labelled erythrocytes between the 
liver and spleen. These included not only 
venesection, hypertransfusion and the transfusion 
of unlabelled denatured erythrocytes, but also 
the injection of NTA—iron. No consistent pattern 
of altered organ uptake could be identified, 
except that the most marked inhibition of release 
seemed to occur in the organ in which uptake 
was less.
THE ROLE OF ASCORBIC ACID IN THE METABOLISM 
OF STORAGE IRON
INTRODUCTION
There is reason to believe that the metabolism 
of ascorbic acid and iron are interrelated. For 
example, scurvy is common in the Bantu people of 
Southern Africa, but it is almost never seen in 
individuals who are not heavily siderotic (Seftel 
et al, 1 9 6 6). Evidence has been obtained that 
irreversible oxidation of a proportion of the 
dietary ascorbic acid occurs, probably mediated 
by the massive tissue deposits of ferric iron 
(Lynch et al, 1 9 6 7)* The severity of the resultant 
ascorbic acid deficiency depends upon the amount 
of ascorbic acid in the diet, and consequently the 
incidence of clinical scurvy varies with the seasons.
Other observations, both clinical and experi­
mental, suggest that deficiency of ascorbic acid 
may, in its turn, affect the metabolism of iron.
In Bantu individuals with severe siderosis the 
plasma iron concentration is typically elevated, 
but if the tissue levels of ascorbic acid are 
depleted, the plasma iron is usually low (Bothwell 
et al, 1964) , The administration of ascoi-bic 
acid to such subjects results in the prompt return
of* the plasma iron concentration to elevated 
levels. This suggests that the release of iron 
to the plasma may be inhibited by deficiency of 
the vitamin. Finally, there are certain experi­
mental observations which strengthen the suspicion 
that the metabolism of storage iron is abnormal 
in the presence of ascorbic acid deficiency. It 
has been reported that deposits of haemosiderin 
are greater than normal in the tissues of scorbutic 
guinea-pigs, while the soluble fraction of liver 
iron is reduced (Banerjee and Chakrabarty, 1 9 6 5).
These various findings are not altogether 
surprising since the results of studies in vitro 
suggest that ascorbic acid may be necessary, 
not only for the incorporation of transferrin- 
bound iron into hepatic ferritin (Mazur et al, 
i9 6 0), but al so for the release of iron from 
ferritin (Mazur et al, 1955). The present 
investigation was undertaken to obtain more 
information on the role of ascorbic acid in
the uptake and release of iron from stores.
Adult male guinea-pigs of the Onderstepoort 
strain were used. The diet consisted of ascorbic 
acid-free guinea-pig/rabbit production pellets 
(Delraas Milling Company, Randfontein, South Africa), 
hay which had been heated to 80°C for 1 hour, and 
tap water. This diet produced frank scurvy in 
28-32 days. Control animals were fed the same 
diet except that ascorbic acid was added to the 
water (l^O mg/l). The experiments were performed 
after 21 days, at which time the mean liver ascorbic 
acid concentrations (isD mean) by the method of 
Roe (l95^) were 0.6(io.5)mg/l00g in the scorbutic 
group and 2^(ip)mg/l00g in the control group.
The mean haemoglobin concentrations (isD mean) were 
13.M~2.l)g/lOOml and I k . l(i2.2) g/lOOml respectively 
and the reticulocyte coiints were normal in all 
animals studied. The mean weights (isD mean) of 
the scorbutic and control groups were 539(~157)g 
and 629(^123)g respectively.
In kinetic studies radioiron was given to 
the experimental animals in one of three ways.
Radioiron bound to transferrin was prepared by
incubating guinea-pig plasma with tracer amounts
59 oof ^FeCl^ for 30 minutes at 37 C. In another
experiment 1000yug iron as ferrous sulphate
59labelled with FeCl^ was injected intravenously.
No immediate effects were observed, and within 15
minutes 70-80^ of the radioactivity was present in
the liver. Finally, erythrocytes containing
59haemoglobin labelled with Fe were prepared by
incubating guinea-pig reticulocytes in vitro with
59Fe of high specific activity, bound to trans­
ferrin. (Fractionation of such cells by the method 
of Gale et al (1 9 6 3) revealed that inox’e than 
of the radioactivity was in the haemoglobin 
residue). Prior to injection the cells were 
rendered non-viable in the following way. After 
washing, the cells were suspended in eight times 
their volume of a 1:1 mixture of 0.9/& NaCl 
solution and ACD (5 g citric acid, 13*8g sodium 
citrate, 1 3 «9g dextrose per litre of solution) 
and heated in a water bath at k y ° C for 4 minutes. 
When erythrocytes which had been treated in 
this way were injected intravenously into normal 
guinea-pigs, almost all the radioactivity was 
present in the liver and spleen after 45 minutes.
In all studies the animals were killed by
bleeding from the aorta under ether anaesthesia.
The portal vein was cannulated and 30 ml 0.9^ 0
NaCl solution was perfused through the liver to
wash out the blood. The liver and spleen were
removed, cooled rapidly on ice, and were then
stored at - 20°C prior to processing. This was
done by thawing and homogenizing the organs in
four times their weight of distilled water. In
the isotopic experiments total body radioactivity
was measured in an Armac Counter. This was also
used for measuring the localization of radioiron
in the liver and spleen. Radioactivity in
ferritin and haemoglobin was determined as
described in Chapter II, but in the present studies
insoluble radioiron was also estimated. A 2 ml
aliquot of the homogenate was heated to 80°C and
the radioactivity in the washed precipitate determined.
Since the radioactivity present in the haemoglobin
was already known, a crude estimate of insoluble
radioiron could be obtained by subtraction. In
59studies in which Fe-haemoglobin was not present, 
the total heat precipitate was taken to represent 
insoluble radioiron. Ferritin iron was measured
by the method of Drysdale and Mimro (1 9 6 5) and 
total non-haem iron by the method of Torrance and 
Bothwell (1 9 6 8). "Haemosiderin", or insoluble 
non-haem iron was then obtained by difference.
RESULTS
NON-HAEM IRON AND FERRITIN IRON CONCENTRATIONS IN 
LIVERS AND SPLEENS OF NORMAL AND SCORBUTIC GUINEA-PIGS
The total non-haem iron and ferritin iron 
concentrations were measured in the livers of 
18 scorbutic guinea-pigs, 18 control animals, and 
11 animals which had been maintained on the ascor­
bic acid-free diet, but which had received an 
intraperitoneal injection of 40 mg ascorbic acid 
2h hours before being killed. Similar determinations 
were performed on the spleens of 10 animals from 
each group.
The effects of ascorbic acid deprivation 
were different in the two organs (Fig l). In the 
liver, the total non-haem iron concentration was 
significantly lower in the scorbutic animals 
than in the controls, mean figures (isD mean) 
being 9 0(^3°)yug/g and 1 3 0 (-3 6)yug/g respectively 
(t^, 3 .6 7 ; P<  O.OOl). In the spleens, on the
other hand, the concentration of non-haem iron 
was significautly higher in the scorbutic animals, 
the mean figure (—SD mean) being 833(—193)yU-g/g
Figure 1, Tota.l non-haem Iron concentrations in 
livers and spleens of control animals (a ), scorbutic 
animals (b ) and scorbutic animals given ascorbic 
acid 2 k hours before analysis (c) . Unhatched=ferr.itin.
compared with only 3 3 9 (-9 0)yug/g in the control 
group (t^g, 7*28; P<0.00l). In both livers and 
spleens the proportion of non—haem iron present 
as ferritin was much lower in the scorbutic than 
in the control animals. In the livers, a mean 
(lSD mean) of 23(ill)$> was present as ferritin in 
the scorbutic guinea-pigs compared with 55 (-8)$> in 
the normal animals (t^, 10.0; P<0.00l). In the 
group of scorbutic animals given an injection of 
ascorbic acid 2h hours before death, the mean (-SD 
mean) non-haem iron concentration din the livers was 
similar to that in the scorbutic animals (7 8 -23yug/g), 
but the percentage of ferritin had risen to a mean 
(lSD mean) of 51 (^2) <Jo. In the spleens of the
scorbutic animals, ferritin formed a mean (^SD mean) 
of only 9(-?~ )io of the total non-haem iron, compared 
with a mean (isD mean) of 4 7(~5)$ in the normal 
animals. In the scorbutic guinea-pigs given the 
injection of ascorbic acid 2 h hours before death, 
the splenic non-haem iron concentration was much 
lower than that in the untreated scorbutic group 
(mean 38 3yug/g, SD mean ^162) (t-^ g, 5*62; PCO.OOl),
and the percentage present as ferritin had risen to 
(isD mean) of ^2(il6)$>„a mean
UPTAKE AND RELEASE OP HEAT-DAMAGED ERYTHROCYTES 
CONTAINING ^Fe-LABELLED HAEMOGLOBIN
Twelve control and 12 scorbutic animals 
received intravenous injections of heat-damaged 
erythrocytes containing 75M g iron as haemoglobin. 
Three guinea-pigs from each group were killed res­
pectively at 45 minutes and 3> 24 and 48 hours. The 
spleen and liver of each animal were homogenized
together and the total radioactivity as well as the
59distribution of the Fe between the various fractions 
determined (Fig 2).
In the control animals a mean (range) of
9 6(90-9 9)$i of the injected radioactivity was
present in the liver and spleen at 45 minutes, but
by 3 hours, the figure had fallen to a mean of 48
(47-49)$ and by 24 hours to 36(35-40)$. In the
59scorbutic animals, less of the injected "^Fe was 
located in the livers and spleens at 45 minutes 
(mean and range, 7 0 (69-8 3)$), but the major 
difference from the control group was that there 
was little change in this figure during the 
course of the experiment. The subsequent means
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59Figure 2. Distribution of Fe in combined livers
and spleens of control and scorbutic animals at
various times after injecting denatured red cells
59containing ^'Fe-haemoglobin. Heavy stipple,
haemoglobin; light stipple, ferritin; hatched, 
insoluble (haemosiderin).
and ranges were: at 3 hours, 7 3 (7 0-7 9 )$; at 24 hours, 
6 3 (6 1-6 5)$; and at 48 hours, 64(62-65)$.
59The rate of disappearance of Fe-labelled 
haemoglobin was somewhat more rapid in the control 
animals. Although the initial uptake o±' denatured 
cells was slightly greater in the control group, 
by 3 hours only a mean (range) of 1 7 (1 5-1 8 )$ of the 
injected radioactivity was still in the form of 
haemoglobin, compared with 3 1 (3 0-3 5)$ In the 
scorbutic guinea-pigs. By 24 hours, however, it had 
all been processed in both groups. The mean percen­
tage (range) of injected radioactivity present 
as ferritin increased slightly in the control 
animals from 13(ll-15)$ at 45 minutes to 24(19-27)$ 
at 3 hours, after which there was little change.
The means and ranges .in the scorbutic guinea- 
pigs were not very different; at 45 minutes ll(9-12)$ 
was in ferritin; at 3 hours 29(27-31)$, at 24 hours 
2 7 (22-3 0)$ and 48 hours 13(12-15)$.
The major difference between the two groups
59was in the fraction of Fe present in the heat 
precipitate after subtracting haemoglobin iron 
(’insoluble iron1). Xn the control guinea-pigs
the mean, figure (range) rose from 2(l-3)$ at 
45 minutes to 10(9-ll)$ at 3 hours, and thereafter 
was 13(l0—15)$ at both 24 and 48 hours. In the 
scorbutic animals, on the other hand, the amount of 
radioactivity in this fraction continued to in­
crease; at 24 hours a mean (range) of 4l(37-44)$ 
was in this form, and at 48 hours the figure had 
risen to 50(47-53)$.
UPTAKE AND RELEASE OF TRANSFERRIN-BOUND ^Fe
Nine scorbutic and nine control animals
were given intravenous injections of 1 ml guinea-
59pig plasma labelled with Fe. Three animals 
from each group were killed at 3, 6 and 24 hours 
respectively, and total hepatic radioactivity 
as well as the percentage present in ferritin and 
heat—insoluble fractions were determined.
The patterns were significantly different 
in the two groups (Fig 3 ). In the control animals, 
the percentage of injected radioactivity present 
in the liver rose from a mean (range) of 1 2(10-1 5 )$ 
at 3 hours to 1 3 (ll-1 5)$ at 6 hours and 1 9 (l6-2 2)$ at 
24 hours. In the scorbutic animals there was also an
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59Figure 3» Distribution of Fe in the livers of
control and scorbutic animals at various times
59after injecting transferrin-bound Fe. Stippled, 
ferritin; hatched, insoluble (haemosiderin).
initial increase in hepatic radioactivity to a
mean (range) of 13(ll-15)% at 6 hours, but at Zk hours
the figure had declined to 8(7-10)%. The distri- 
59bution of Fe between the ferritin and heat- 
insoluble fractions was not very different in the 
two groups, the proportion which was insoluble 
being slightly more in the scorbutic animals.
This experiment was repeated using six control 
and six scorbutic guinea-pigs, all of which had 
been hypertransfused with homologous packed red 
cells 7 and 6 days previously in order to inhibit 
erythropoiesis. Haemoglobin values ranged between 
Zb and Z6 g/100 ml. Three animals from each group 
were killed at 3 hours, and the remaining three at 
6 hours. The mean percentage (range) of injected 
radioactivity in the livers of the control animals 
was 1 5 (l3-l6 )% at 3 hours and 2 0(l8~2 3)% at 6 hours, 
while in the scorbutic group the corresponding 
figures were 20(15-22)% and 30(23-36)%. The 
mean percentages of injected radioactivity present 
in the form of ferritin at these times were 
similar in the two groups, but greater amounts 
were present as insoluble iron in the scorbutic
animals. The mean figures (range) at 6 hours were 
7(6-9)$ and 15(12-19)$ in the control and scorbutic 
groups respectively.
UPTAKE AND RELEASE OF ^FeSO^
Twelve scorbutic and 12 control animals
were given intravenous injections of lOOOyug 
59iron as FeSO^. Three animals from each group 
were killed at 12 hours, and 2, 4 and 6 days 
thereafter, and the total hepatic radioactivity 
together with the fractions present as ferritin 
and as insoluble iron determined.
The results resembled those obtained with 
59plasma-bound Fe. Initially similar percentages 
of injected radioactivity were present in the 
livers of each group, the mean figures (range) at 
12 hours being 7 6 (7 ^-7 7 )$ and 6 8(6 5-7 1 )$ in scorbutic 
and control animals respectively. Thereafter 
there was a steady decline in radioactivity in the 
scorbutic group, whereas in the control animals the 
figures remained high. At 6 days the mean figures 
(range) were 39(38-^1)$ and 7 2 (7 0-7 3 )$ respectively.
DISCUSSION
In the present study ascorbic acid deficiency 
was found to produce changes in the distribution 
of storage iron in guinea-pigs. The total non-haem 
iron concentration was lower in the livers and 
considerably higher in the spleens of the scorbutic 
animals than it was in the controls (Fig l). Not 
only was there a redistribution of storage iron between 
the two organs, but the proportion present in 
each of the two iron storage compounds was also 
different, much less being present as ferritin 
and much more as haemosiderin. These results con­
firm and extend those of Banerjee and Chakrabarty 
(1 9 6 5), who reported a higher total iron concentra­
tion in the spleens of scorbutic guinea-pigs 
compared with pair-fed control animals; in the 
livers the total iron concentration was not dimini­
shed, but in the scorbutic group the soluble iron 
fraction was smaller and the insoluble fraction 
larger. In the present study it was possible to 
demonstrate the role of ascoi’bic acid deficiency 
in the production of these changes. After a single 
intraperitoneal injection of the vitamin 2 b hours
before death, there was a drop in mean total 
non-haem iron concentration in the spleens of 
the treated animals to less than half that in 
the untreated group. This indicated that a con­
siderable amount of storage iron had been re­
leased. In addition, there was a very consider­
able decrease in haemosiderin and an absolute 
increase in the amount of ferritin, which now 
formed more than half the total as compared 
with less than 10$ in the scorbutic animals.
In the livers the relative proportions of the two 
storage compounds also returned to normal on 
injecting ascorbic acid, but the total non-haem 
iron concentration did not change significantly.
These observations suggest that the balance 
between ferritin and haemosiderin is shifted 
towards the insoluble form in the presence of 
ascorbic acid deficiency, and that the balance 
is rapidly restored when the deficiency is corrected. 
In this connection, the observations in vitro of 
Matioli and Baker (1 9 6 3) may be relevant. These 
workers have obtained evidence suggesting that 
haemosiderin is formed as a result of the oxidative 
denaturation of ferritin. It therefore seems
possible that the proportion of storage iron 
present in each form might be influenced by the 
cellular concentration of a reducing agent such 
as ascorbic acid.
The increase in total storage-iron concen­
tration in the spleens of the scorbutic animals 
together with the decrease in the livers suggested 
that ascorbic acid deficiency might have different 
effects on the release of iron from stores in 
different types of cell. This possibility was 
strengthened by the marked effect on splenic-iron 
release when ascorbic acid was administered to 
scorbutic guinea-pigs, and the absence of such an 
effect in the liver. Hepatocytes might conceivably 
be capable of different metabolic reactions from 
reticulo-endothelial cells. However, since hepatic 
storage-iron is located not only in hepatocytes 
but also in cells of the reticulo-endothelial 
system,' further studies were necessary in order
to test this hypothesis. Iron within each cell
59type was separately labelled with Fe by injecting 
the isotope in different forms. It is generally 
agreed that damaged red cells are not engulfed by
hepatocytes, so that Pe in the form of haemo-59
globin within heat-denatured red cells was located
in reticulo-endothelial cells, in the liver as
well as in the spleen (Hosain et al, 1 9 6 2). Iron
bound to transferrin, on the other hand, does not
enter reticulo-endothelial cells (Hosain et al,
1 9 6 2). Most of it is taken up by the erythroid
bone marrow and incorporated into developing red
cells, but a fraction goes to the liver and enters
hepatocytes. Furthermore, free iron injected
intravenously is predominantly taken up by the
parenchymal cells of the liver (Finch et al, 1950)•
The effect of ascorbic acid deficiency upon the
59uptake, storage and release of Fe injected in 
these three forms was therefore studied.
Significant differences between scorbutic
and control guinea-pigs were observed (Fig 2).
In normal animals, iron was rapidly freed from
haemoglobin and released into the plasma, whereas
59in. scorbutic animals very little Fe left the 
reticulo-endothelial cells. There was, in addition, 
some suggestion that a smaller percentage of the 
damaged erythrocytes had been taken up by the
scorbutic animals, and that the rate of libera­
tion of iron from haemoglobin was slower. Much 
more striking, however, was the progressive 
build-up of radioactivity in haemosiderin (heat- 
insoluble fraction) in these animals, whereas in 
the control animals there was little change after 
the first 3 hours. These observations therefore 
provide support for the suggestion that the effect 
of ascorbic acid deficiency is to inhibit the 
release of iron from reticulo-endothelial cells, 
and to promote the formation of haemosiderin at 
the expense of ferritin.
The behaviour of hepatocytes in terms of the 
handling of storage iron was found to be different 
to that of reticulo-endothelial cells (Fig 3)•
K QWhen -^Fe-labelled plasma was injected intraven­
ously there was a steady build-up in hepatic 
radioactivity between 6 and 2 b hours in the control 
animals. However, in the scorbutic animals the
radioiron levels diminished over the same period,
59thus indicating a release of Fe into the plasma.
These conclusions were confirmed by the results of
59the experiment with FeSO^.
Mazur et al (i9 6 0) have suggested that
ascorbic acid is necessary for the incorporation
of plasma iron into hepatic ferritin. However,
no evidence to support this contention was obtained
in the present study. In the experiment in which
erythropoiesis was inhibited by hypertransfusion,
similar quantities of labelled ferritin were
59formed from plasma-bound Fe in both control 
and scorbutic animals, while the total percentage 
incorporated into storage complexes (ferritin + 
haemosiderin) was actually greater in the scorbutic 
group.
The observations made in the present study 
may well have relevance to the cellular and organ 
distribution of storage iron in Bantu subjects 
with iron overload. The siderosis in these indivi­
duals is a consequence of the excessive amounts 
of available iron in the diet, and over the years 
there is a steady accumulation of iron in storage 
depots (Walker and Arvidsson, 1953 > Bothwell and 
Bradlow, i9 6 0). In the majority of affected subjects 
the most striking deposits are found in reticulo­
endothelial cells throughout the body. This
distribution differs from that found in idiopathic 
haemochromatosis, in which reticulo-endothelial 
deposits are much less prominent than those in 
parenchymal cells. The differing hepatic locali­
zation of iron in the two conditions has, in fact, 
been shorn to be distinctive enough to allow for 
differentiation on histological appearances alone 
(Bothwell et al, I9 6 5)• Several possible reasons 
for the difference in iron distribution have been 
advanced, and it has even been suspected that it 
may hold a clue to the aetiology of the idiopathic 
condition. The results of the present study, 
however, suggest that the answer may lie in the 
low ascorbic acid content of the Bantu diet (Lynch 
et al, 1 9 6 7) compared with that of most subjects 
with idiopathic haemochromatosis. Significant 
deficiency of ascorbic acid in the Bantu might 
inhibit the release of iron from reticulo-endothe­
lial sites sufficiently to allow for the slow 
accumulation of storage iron in these cells. This 
notion is supported by the low serum-iron concen­
trations in such subjects when frank scurvy is 
present, and the sharp increase in serum-iron
concentration on administering ascorbic acid 
(Bothwell et al, 1964). Although this suggests 
that the release of iron from stores is inhibited, 
it should be noted that the plasma-iron turnover 
in scorbutic Bantu is usually between two and 
three times normal, and that it does not change 
when ascorbic acid is first administered (Bothwell 
et al, 1964). It is obvious, therefore, that a 
considerable amount of iron does enter the plasma 
in scorbutic individuals; the present study suggests 
that most of it comes from hepatic parenchymal 
cells rather than reticulo-endothelial cells. 
Unanswered questions relate to the factors respon­
sible for the increased release of iron from 
hepatocytes under these circumstances, and the 
relationship (if any) between the inhibition of 
iron release from reticulo-endothelial cells and
the enhanced conversion of ferritin to haemosiderin.
CHAPTER XV
THE SITE OF ACTION OF DESFERRIOXAMINE
INTRODUCTION
Desferrioxamine methanesulphonate (DFA) is an 
iron, chelate of great avidity and selectivity. The 
DFA-induced urinary iron excretion is a valuable 
diagnostic test of iron overload (Balcerzak et al. 
1 9 6 8; Ploem et al, 1 9 6 6), and provides a good 
assessment of normal and deficient iron stores 
(Dagg et al, 1 9 6 6; Hallberg and Hedenberg, 1 9 6 7).
In spite of investigation by a number of workers, 
the source of the iron chelated by DFA remains 
uncertain. There is, however, agreement on the 
sources which are not available to the chelate.
Iron bound to transferrin in the plasma is not re­
moved in vivo (Hallberg and Hedenberg, 19 6 5a; 
Balcerzak et al, 1 9 6 6), and the incorporation of 
plasma-bound radioiron into the haemoglobin of new 
red cells is unchanged when DFA is injected (Hallberg 
and Hedenberg, 1 9 6 5a). Haemoglobin iron is inviolate 
(Keberle, 1964) and there is nothing to implicate 
myoglobin and other functional iron compounds. While 
iron in process of absorption from the intestine 
can be bound, it does not represent an important 
chelatable pool (Brown et al, 1 9 6 7,* Hallberg and
Hedenberg, 1965b; Hedenberg, 1 9 6 9).
On balance it would seem that the storage 
compounds ferritin and haemosiderin represent the 
major source, since the quantity of iron chelated 
is roughly proportional to the quantity of storage 
iron in the body (Fielding, 1 9 6 5; Ploem et al,
1 9 6 6; Hallberg et al, 1966 ; Balcerzak et al, 1 9 6 8). 
Furthermore, DFA has been shown to remove some 
iron from ferritin in vitro (Wohler, 1964), and 
also from liver homogenates, the amount being 
proportional to the non-haem iron concentration 
(Hedenberg, 1 9 6 9). Certain observations, however, 
suggest that at least some of the iron chelated 
in vivo has a different immediate origin. For 
example, DFA—induced urinary iron excretion is 
often high in patients with pernicious anaemia 
(Fielding, 1 9 6 5? Karabus and Fielding, 1 9 6 7), and 
shortly after starting treatment there is a rapid 
drop unrelated to any significant change in the 
amount of storage iron (Hallberg, 1964; Karabus and 
Fielding, 1 9 6 7; Balcerzak et al, 1 9 6 8). Additional 
evidence suggesting that DFA is able to chelate 
iron which is not in fixed storage compounds is 
provided by the effect of the transfusion of non-
viable erythrocytes. DFA—induced urinary iron
excretion doubles between h and 8 hours after 
such a transfusion before returning to normal at 
20 hours (Hedenberg, 1 9 6 9)• Such observations 
suggest that iron in transit both to and from the 
stores can be chelated, but it remains uncertain 
whether this represents a major or a minor source 
of the iron bound by desferrioxamine. These 
observations are, in addition, of special relevance 
to this thesis, for they suggest that alterations 
in the amount of iron processed by reticulo­
endothelial cells results in alterations in the 
quantity of iron excreted after injecting the chelate
Another area of uncertainty relates to the 
cellular origin of the chelated iron. The major 
physiological pathway for iron involves the break­
down of senescent red cells in reticulo-endothelial 
cells, with subsequent delivery of the released 
iron into the plasma. Much of the storage iron 
of the body is in these cells, but there is also 
some in parenchymal cells, particularly those of 
the liver. In states of iron overload the deposits 
of storage iron are increased in all tissues, but 
not necessarily to the same extent. Harker et al
(1 9 6 8) have produced evidence to suggest that the 
iron chelated by DPA may originate largely or 
entirely from parenchymal cells. They found that 
the amount of iron excreted after the injection 
of DFA was more closely correlated with the 
quantity of histologically visible iron in hepatic 
parenchymal cells than with the amount in reticulo­
endothelial cells.
The present study was done in an attempt to 
shed light on some of these problems. The 
cellular origin of the chelated iron was studied 
by labelling the storage iron in the two cell 
types separately. In addition, the rate of 
release of storage iron into the plasma was 
manipulated in various ways in an attempt to 
define more closely the chemical source or sources
of the chelated iron.
MATERIALS AND METHODS
Adult male rats of the Sprague-Dawley strain 
weighing between 200 and 300 g were used. In some 
experiments erythropoiesis was inhibited by hyper­
transfusion or stimulated by venesection as 
described in Chapter II.
Transferrin-bound radioiron was prepared by
incubating buffered rat plasma with a tracer 
59amount of Fe Cl^. In order to prepare radio­
active ferritin, 30 /^ug iron as ferrous sulphate
59labelled with 10^uc FeCl^ was injected intra­
venously into a rat. One hour later the rat was 
killed, and ferritin was prepared from the homo­
genized liver by precipitation with ammonium 
sulphate after heating (Drysdale and Munro, 1 9 6 5). 
After precipitation it was redissolved in isotonic
saline. Erythrocytes containing haemoglobin 
59labelled with Fe were obtained as described in 
Chapter II.
Desferrioxamine methanesulphonate (Desferal, 
Ciba) was supplied in sterile vials containing 
500 mg crystallized powder, which was dissolved in
isotonic saline immediately prior to use. Control 
animals received injections of1 isotonic saline.
A Packard whole-body Armac counter was used
to measure the radioactivity present in the total
animal and in individual organs. Excretion of
59Fe was assessed by determining the decrease in
whole-body counts after allowing for decay. The
59methods for determining Fe in ferritin and in 
haemoglobin have been described above (Chapter Xl) 
Radioactivity present in circulating erythrocytes 
was determined by counting an aliquot of blood.
The percentage red-cell utilization of radioiron 
was calculated on the assumption that the blood 
volume was 5 0 ml/kg body weight in normal and 
bled animals and 60 ml/kg in polycythaemic animals 
The total non-haem iron content of the livers and 
spleens was estimated chemically by the method of 
Torrance and Bothwell (1 9 6 8).
EFFECT OF ERYTHROID MARROW ACTIVITY UPON QUANTITIES 
OF CHEMICAL IRON CHELATED BY DESFERRIOXAMINE
Forty rats were given intramuscular dlnjections 
of 5 nig iron as iron sorbitol citrate (jectofer, 
Astra) on the eighth and seventh days prior to 
commencing the study. They were then randomly 
divided into two groups, one of which was hyper- 
transfused on the same two days and also on the 
first day of the study. The mean packed cell 
volume at this time was 69%. Each group was 
subdivided again to yield four groups of 10 rats 
each; 10 hypertransfused and 10 normal rats then 
received intramuscular injections of 10 mg DFA 
twice daily for 1h days, while the remaining 
animals were given injections of isotonic saline.
On the fifteenth day all the animals were 
killed and the non—haem iron contents of their 
livers and spleens were determined. The figures 
were closely similar in the two hypex’transfused 
grotips. The mean total liver non-haem iron (- SD 
mean) was ^,6l^(-958) yUg in the hyper transfused
animals given DFA and k , 390(-1, 0^1)yug in those 
given isotonic saline, while the splenic non-haem 
iron contents were 6 3 6(^5 )yug and 6 3 4(^6)yug 
respectively. In contrast, the concentrations 
in the normal rats given DFA were significantly 
lower than those in the animals given isotonic 
saline. Mean hepatic values (i SD mean) were 
1,^93(±84) yug and 2,328(^272)yug respectively 
(t 9»3» P<0.00l), while the comparable 
splenic figures were 18^(152)yug and 26o(iSO)yug 
(t^Q, 2.5; 0.05> P < 0.02). Approximately 900yug 
iron had thus presumably been removed by DFA from 
the two organs.
EFFECT OF ERYTHROID MARROW ACTIVITY UPON QUANTITIES 
OF RADIOIRON CHELATED BY DESFERRIOXAMINE
Transferrin—bound radioiron
59Tracer quantities of Fe bound to plasma 
were injected intravenously into 22 rats. Pre­
liminary experiments in normal rats revealed that
59the Fe was cleared exponentially from the plasma 
with a mean half time of 66 minutes. Ton animals
received injections of 10 mg DFA inimediately
following the injection of radioiron, and there­
after intramuscularly each hour for 3 hours. The 
remaining 12 animals acted as controls. After 4 
hours, three rats from the DPA group and four 
control animals were killed. Further injections 
of DFA were given at 12, 24 and 36 hours. Half 
the remaining animals in each group were killed 
at 24 hours and the remainder at 48 hours.
A mean of l6.8^ of the injected radioactivity 
was in the livers of the control animals at 4 hours 
and this amount changed very little during the 
course of the experiment (Table i). By 48 hours 
a mean of 7 -5$ had. been excreted by this group, 
and virtually all the remaining radioiron could 
be accounted for in circulating erythrocytes.
The administration of DFA did not significantly 
affect the amount of radioiron incorporated into 
x’ed cell haemoglobin at 48 hours, but more "^Fe had 
been excreted (mean 14.2^) and less was in the 
liver (mean 3.8fo) than in the control group.
The difference between the two groups in terms of
hepatic radioactivity was apparent as early as
, 594 hours after injecting the Fe.
TABLE I
EFFECT OF DESFERRIOXAMINE (DFA) ON THE DISTRIBUTION OF RADIOIRON IN NORMAL RATS AT VARIOUS TIMES
AFTER THE INJECTION OF ^Fe-LABELLED PLASMA
Time after injection
4 hr 24 hr 48 hr
DFA Control DFA Control DFA Control
No. of rats 3 4 3 4 4 4
Mean fo in liver 7.4 1 6 .8 8.4 1 6 .2 5.8 1 3 .6
(6.7-8 .3 ) (1 6 .2-1 7 .6) (6.1-10.2) (14.4-17.5) (5.4-6.2) (11.4-15.6)
Mean fo in 4.1 11.3 5-2 11.6 3-0 9-5
hepatic ferritin (3.2-4.5) (10.6-12.6) (3.4-6.8) (9.5-13.5) (2 .6-3 .5) (8 .8-1 1 .0)
Mean fo in - - 1 7 . 8 24.7 5 8 .0 6 1 .1
circulating red. cells (9.3-31.8) (16.9-29.4) (4 9 .0- 7 0 .9 ) (4 9.7-6 8.0 )
Mean fo excreted - - 18.8 6.8 14.2 7.5
(11.2-19.7) (4.9-7.4) (1 0.8-1 6.2 ) (5.1-10.5)
The range of results is given in parentheses.
The experiment was repeated us ding 14 hyper- 
transfused animals, but observations were made only 
at 4 and 24 hours. After 2 k hours less than 3$’ 
had been incorporated into circulating erythrocytes, 
thus reflecting the successful inhibition of 
erythropoiesis. In the control animals the amount
59of ^Fe in the liver increased from a mean(range) 
of 13.7(11.4-15.2)$ at k hours to 29-6(28.2-32.1)$ 
at 2k hours whereas in the previous experiment 
there had been no significant change after k hours. 
The mean(range) corresponding figures in the 
hypertransfused rats given DFA were 5•5(4.7-5•8)$ 
and 15.7(7-6-20.5 )$ respectively. The mean(range) 
percentages excreted after 24 hours were virtually 
identical to those in the previous experiment, 
namely 5-2(2.5-7-0)$ in the control rats and
19.l(l7-^—20.5)$ i-11 those given DFA.
59Ferritin labelled with 7Fe.
The distribution of intravenously injected
/ 59 \ferritin was first examined. ( Fe)—ferritin 
containing 5 9 y u g iron was injected into eight 
normal rats, half of which were killed after 2 hours 
and the remainder after 24 hours. At both times
all the radioactivity was px'esent in the livers, 
and approximately 75$ could still be identified 
as ferritin. The same amount of labelled ferritin 
was then injected into 10 normal rats. After 24 
hours half the rats were given intramuscular injec^  
tions of 10 mg DFA twice daily for 16 days, while 
the remainder received isotonic saline injections. 
In the control animals at this time only a mean 
(range) of 5 0. 2(33* 3-66 . 4)$ of the injected radio­
activity remained in the liver, 32.8(21.3-47*8)$ 
being ferritin. A mean(range) of 22.6(17.5-30.4)$ 
was in circulating erythrocytes and l6.6(ll.O- 
19.6)$ had been excreted. In the animals given 
DFA a similar amount had been incorporated into 
red cells (mean 26.3, range 21,0-34.2)$ but 
a considerably greater quantity had been excreted 
(mean 57*7, range 54.5-63*2)$, and this was 
reflected in the lower figure for hepatic radio­
activity (mean 21.5, range 9 *3-3 0*2)$; 10.1 
(range 2 .9-1 3 *5 )$ was in ferritin.
A similar experiment was performed on nine
hypertransfused animals, but on this occasion
/ 59 \only 30 ,ug iron as (/ Fe)-ferritin was injected.
Two animals were killed at 3 hours, when once
again all the injected radioactivity was present
in the liver. A mean of 72.3/ was identifiable
as ferritin. Three of the remaining rats received
intramuscular injections of 10 mg DFA twice daily
for 8 days, while four animals acted as controls.
Further transfusions of 3 ml packed homologous
erythrocytes were given on the first, third and
sixth days. On the eighth day the animals were
killed, at which time there was no radioiron in
circulating erythrocytes. The control animals
had excreted a mean(rango) of 5•0(4.1-7 * 2)/ of 
59the Fe, while the animals given DFA had excreted 
a mean(range) of 55 • 7 (5^ + • 5-63• 2)/>. All the re­
maining radioactivity in both groups of animals 
was in the livers. A mean(range) of 73*2(68.3- 
77.5)$. of injected radioactivity was still present 
as ferritin in the control animals, while the 
corresponding figure in the DFA group was 3 6 .0 
(30.1-39.6)/*.
/ 59 \The third experiment using ( Fe) —ferx’itin 
was performed on 12 animals in which erythropoie— 
sis had been stimulated by venesections. On this
occasion only a mean(range) of 82.2(80.8-84.7)$ 
of the 30yug injected ferritin iron was in the 
liver at 2 hours, and this had diminished to 
l6.0(12.1-24.1)$ in the five control animals killed 
after 6 days. A mean(range) of 14.2(l2.6-l6.4)$ 
had been excreted at this time, while the remainder 
(mean ^ 6 .0, range 49 • 3—59* 0)$ was in circulating 
erythrocytes. The five rats given DFA injections 
in the same way as before had excreted a mean(range 
of 45.8(40.0-50.3)$ of the radioiron. It was 
noteworthy that in this experiment the amoiint of 
radioactivity in circulating haemoglobin was a good 
deal less in the DFA animals than in the controls 
(mean 37-0, range 32.3-40.2)$. Only a mean(range) 
of 8.1(6.2-11.3)$ was still din the liver, with 
3.7(l.6-6.l)$ as ferritin.
Pleat-damaged erythrocytes.
Damaged red cells containing 50yug iron as 
/ 59 \( Fe)-haemoglobin were injected into 21 normal 
animals. After 45 minutes three of the animals 
were killed, and the remaining rats were divided 
into equal groups. An intravenous injection of
10 mg DFA was given to the one group at this time, 
and this was followed by an intramuscular injec­
tion of the same amount every hour for 3 hours.
Three animals from each group were killed at 4,
24 and 48 hours respectively.
At 45 minutes virtually all the injected
radioactivity was in the livers and spleens, but
by 4 hours the figure had diminished to almost
half (Table II). Thereafter it continued to
decline, but at a slower rate. In the animals
given DFA the figures were somewhat lower at each
time, but the differences were small. Excretion
of radioiron after 48 hours was less than irfo in
the control group, but in the animals given DFA
it rose from a mean of 6 . at 4 hours to 15*1^
59at 48 hours. Almost identical amounts of ' Fe 
were incorporated into circulating erythrocytes 
in both the control and the desferrioxamine groups.
In a final study, nine hypertransfused animals 
were given the same amount of labelled haemoglobin 
iron in denatured erythrocytes as in the previous 
experiment. On this occasion, however, no procedures 
were carried out before 24 hours, at which time
TABLE II
EFFECT OF DESFERRIOXAMINE (DFA) ON THE DISTRIBUTION OF RADIOIRON IN RATS AT VARIOUS TIMES AFTER THE 
INJECTION OF DENATURED ERYTHROCYTES CONTAINING 50yug ^Fe IN HAEMOGLOBIN
Time after injection
45 min 4 hr 24 hr 48 hr
Control DFA Control DFA Control DFA Control
No. of rats 3 3 3 3 3 3 3
Mean fo in liver 99.0 51.7 54.8 3 2 .2 46.0 3 0. 0 37.5
and spleen (98.4-99.9) (48.7-55-5) (47.1-62.9) (25.7-36.4) (37.6-54.7) (23.9-37.1) (35.0-41.8)
Mean fo in hepatic 8.9 24. 2 30.3 14.2 2 1 . 7 14.1 2 0 .8
and splenic ferritin (8 .7-9.2) (2 2.8-2 5.9) (1 8 .1-3 6.6) (1 1 .8-1 5 .5 ) (1 7 .8-2 9.5 ) (9.7-19.2) (19.9-21.9)
Mean fo in hepatic and 83.9 12.8 13.7 2.1 4.2 0.4 0.3
splenic haemoglobin (81.5-86.2) (ll.1-14.8) (12.9-14.8) (1.2-3.3) (3 .5-5 .1 ) (0.0-0 .6 ) (0.1-0.5 )
Mean 0^ in circulating 
erythrocytes
— — 2 3. 2
(14.3-33.8)
3 1 . 5
(2 8.6-3 4 .2)
48.2
(45.0-54.0)
47.9
(43.4-49.2)
Mean fo excreted 6.6
(5-1-9.5)
0 .6
(0.0-2.9 )
11.6
(9.5-15.4)
15.1
(11.7-20.0)
1 .0
(0.0-1 .3 )
The range of results is given in parentheses.
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three animals were killed. Virtually all the 
radioactivity was present in the livers and spleens. 
Three of the remaining animals were given intra­
muscular injections of 10 mg DFA twice daily for 
8 days, the control rats receiving injections 
of isotonic saline, and further transfusions of 
3 nil packed homologous erythrocytes were given at 
24 hours, 3 days and 6 days. When the animals 
were killed after 8 days, the controls had excreted 
a mean(range) of 4.8(0.3-11.2)$ compared with 
47.4(41.0-49.8)$ in the DFA animals. Virtually 
all the remaining radioiron was in the livers and 
spleens in both groups, a mean(range) of 59*7 
(54.5-63»3)$ being present as ferritin in the 
control rats and 23.0(21.9-24.3)$ in the DFA rats. 
Less than 2$ had been incorporated into circulating 
erythrocytes in either group.
Under most circumstances the quantity of
iron excreted after an injection of DFA is at
least roughly proportional to the amount of
storage iron in the body. This suggests that
the iron storage compounds ferritin and haemo-
siderin must be the ultimate source of the
chelated iron. Support for this concept was
obtained in the present study. Ferritin labelled
59with Fe was injected intravenously and was
rapidly taken up by the liver. This iron appeared
to enter the physiological circuit, since a large
59proportion of the Fe was incorporated into
haemoglobin during the succeeding days. In the
59animals given DFA some of the Fe was chelated
and excreted, but without affecting the supply of
isotope to the bone marrow. When the marrow
demand for iron was stimulated by prior venesec-
59tions, however, there was not enough Fe to 
supply both erythropoiesis and DFA; in this 
experiment a mean of only 37^ of the injected 
radioactivity was present in circulating erythro­
cytes in the DFA group compared with a mean of
56/o in the control animals. It is therefore 
apparent that the chelate was binding iron des­
tined for incorporation into haemoglobin. However, 
this must have occurred prior to the entry of 
the iron into the plasma, since the results of 
several previous investigations (Hallberg and 
Hedenberg, 19 6 5a; Balcerzak et al, 1 9 6 6) indicate 
that DFA does not chelate transferrin-bound iron 
in vivo.
While these findings supported the concept 
that ferritin is the ultimate source of the iron 
chelated by DFA, they did not define whether iron 
is removed directly from ferritin by the chelate, 
or whether some other iron compound or compounds 
in equilibrium with storage iron is the proximate 
source. The same holds for studies by other 
workers, in which the ferritin concentrations in 
the livers and spleens of rabbits and rats were 
shown to be significantly reduced by the admini­
stration of DFA (Wohler, 1964; Gumming et al,
1 9 6 9). More over, in the present study it was not 
possible to estimate the actual quantities of iron
excreted by the animals in the experiments using
Fe without making assumptions concerning the 
sizes of the pools labelled by the isotope. These 
difficulties were, however, overcome in the experi­
ment in which the storage iron contents of the 
livers and spleens were estimated chemically. The 
results obtained indicate that the iron storage 
compounds are not the major immediate source of 
the chelated iron. There was approximately 9 0 0 y U g  
less non-haem iron in the livers and spleens of the 
rats given DFA injections than in the control 
animals, and this iron had presumably been chelated 
and excreted. In contrast, there was no signifi­
cant differences between the storage iron concen­
trations in the organs of the hypertransfused rats 
given DFA and those given saline. By inhibiting 
erythropoiesis, hypertransfusion reduced greatly 
the amount of iron released from the stores into 
the plasma. If ferritin or haemosiderin were 
the immediate source of the chelated iron, this 
would not be expected to decrease the amount of 
iron bound by DFA in the hypertransfused animals,
On the contrary, more should have been chelated, 
since the stores were lax’ger in these animals.
The fact that the DFA—induced iron excretion was
reduced by hypertransfusion suggests strongly 
that the chelate obtains iron predominantly from 
some compound or compounds on the pathway between 
ferritin and plasma transferrin.
Experiments with radioiron demonstrated that
chelation of iron from the liver and spleen was
not totally abolished by hypertransfusion. In
59whatever form the Fe was introduced, the radio­
activity present in the organs diminished signifi­
cantly when DFA was injected. This was noted not 
only in normal rats but also in animals in which 
erythropoiesis had been suppressed by hypertrans­
fusion. It should, however, be noted, that there 
is still some exchange between stores and plasma 
under such circumstances. On this basis the 
apparent discrepancies between the chemical and 
isotopic data suggest that it is only the most 
recently deposited iron which participates in 
this exchange.
The nature of the iron compound (or compounds) 
vulnerable to the chelate remains a matter for 
speculation. Little is known about the processes 
involved in the liberation of iron from haemoglobin
and its subsequent re-entry into the plasma or 
incorporation into storage compounds. It is, 
however, known that there is only limited exchange 
between pre-existing storage iron and iron re­
leased into the plasma from catabolized haemoglobin 
(Garby and Noyes, 1959^)• It seems reasonable 
to postulate that after seperation from the 
porphyrin the iron enters a pool from which it 
may be taken up by transferrin or be incorporated 
into ferritin. Karabus and Fielding (1 9 6 7) suggest 
that iron released from stores passes through the 
same pool before entering the plasma. There is 
some indirect evidence as to the form of iron 
passing through cells en route to transferrin.
In the previous chapter evidence was presented 
that the reducing agent ascorbic acid is necessary 
for the release of catabolized haemoglobin, iron 
to transferrin. In addition the vitamin is 
necessary for the release of iron from ferritin 
in reticulo—endothelial cells, while xanthine 
oxidase has been shown to play a part in the liver 
(Mazur et al, 1938). These findings suggest that
iron from both ferritin and haemoglobin must be 
converted to the ferrous form at some stage prior
to its release to plasma. Since both transferrin 
and DFA bind only ferric iron, the re-oxidation 
of the released iron must presumably occur’ before 
it is chelated by them. Experiments with copper- 
deficient swine suggests that this may be brought 
about by caeruloplasmin (Lee et al, 1 9 6 8; Ragan 
et al, 1 9 6 9). This enzyme acts intravascularly 
(Roeser et al, 1970)• It seems reasonable, there­
fore, to postulate that iron is delivered to the 
cell membrane in the ferrous form where it is 
oxidized and thus becomes available for chelation 
by either transferrin or DFA.
The findings of this investigation indicate 
that the amount of iron chelated by DFA depends, 
not only on the quantity of storage iron but also 
on the amount of iron delivered to the cell membrane 
for release to transferrin. Since under most 
circumstances DFA—induced urinary iron excretion 
correlates well with the amount of storage iron, 
an equilibrium must exist between the quantity of 
iron in ferritin and haemosiderin and the quantity 
at the cell membrane at any one time. When marrow 
demands for iron are suppressed, this equilibrium
presumably shifts so that less reaches the cell
membrane and less is chelated by DFA. The results 
of previous investigations support this hypothesis. 
Administration of ascorbic acid to scorbutic iron 
loaded Bantu results in a prompt rise both of the 
plasma iron (Bothwell et al, 19^4; Wapnick et al, 
1 9 7 0) and of the quantity of iron excreted after 
injecting DFA (¥apnick et al, 1 9 6 9). Further­
more, administration of non—viable erythrocytes 
similarly leads to an increase in both the amount 
of iron delivered to the plasma (Noyes et al, i9 6 0) 
and the DFA-induced urinary iron excretion (Heden— 
berg, 1 9 6 9). Finally at the commencement of 
therapy of pernicious anaemia with vitamin B^^ a 
prompt fall in both DFA-induced urinary iron 
excretion (Karabus and Fielding, 1 9 6 7) and the 
plasma iron concentration and plasma iron turnover 
is noted (Finch et al, 1956). Once again, there­
fore, less iron is being released to transferrin 
and less iron is consequently chelated by DFA.
Information was also obtained concerning the 
question of the cellular origin of the iron 
chelated by DFA. Although it has previously been
shown (and confirmed in the present study) that 
iron stores are diminished in both spleen and 
liver by the administration of DFA (kbhler, 1964; 
Cumming et_al, 1 9 6 9), it is not possible to deduce 
from this that iron in both organs was directly 
chelated. The possibility that only one of the 
organs was supplying iron to the chelate, so that 
a greater proportion of the iron for erythropoiesis 
was provided by the other, cannot be excluded.
The experiments with radioiron in the present 
study have, however, provided evidence that iron 
within hepatic parenchymal cells and hepatic and 
splenic reticulo-endothelial cells is chelated by 
DFA. Labelled iron was introduced into the differ­
ent cell types by injecting heat-denatured 
erythrocytes in one set of experiments and trans­
ferrin-bound iron in the other. Damaged erythrocyte 
are engulfed by reticulo-endothelial cells, and 
not by the cells of the liver parenchyma, whereas 
the fraction of transferrin iron which is not 
taken up by the red cell precursors enter paren­
chymal cells, and not reticulo-endothelial cells 
(Finch et al, 1 9 6 5)• Radioiron was introduced in 
both forms, and as early as h hours after the start
of the experiments considerable differences were
observed between the DFA and control rats with
regard to the amounts of radioactivity present
in the organs. Little re-distribution could have
occurred at this stage, so that it seems reasonable
59to conclude that the chelate obtained Fe from 
both cell types. The quantitative importance of 
each of these sources could not, however, be 
calculated, as this would involve assumptions 
concerning the size of the pools in which the
radioiron was diluted.
SUMMARY
The factors modifying the release of iron from 
reticulo-endothelial cells were studied din rats by 
injecting heat-denatured erythrocytes containing
/59 \ ^ Fe) -haemoglobin. The cells were rapidly taken 
up by the liver and spleen, and a proportion of the
59Fe was released into the plasma, the maximum rate
being between one and four hours after injection.
59The remaining Fe was incorporated into storage
compounds. A ten-fold variation in the load of
denatured erythrocytes produced a proportional
change in the amount of iron released, the percentage
59remaining constant. Percentage release of Fe
was enhanced in venesected rats and diminished in
hypertransfused rats. Release was inhibited by
injecting either unlabelled denatured erythrocytes
59or NTA—iron before the ^Fe—labelled cells, the
maximum effect being obtained if the interval between
the two injections was 3-9 hours. Release was also
inhibited by injecting NTA-iron 30 minutes after
the denatured labelled erythrocytes. Inhibition
was always preceded by a rise in' the serum iron
concentration, and was associated with an increase
59in the percentage of Fe incorporated into ferritin. 
It is postulated that the shortage of free binding
sites for iron on transferrin delays the entry of 
liberated haemoglobin iron into the plasma, and 
consequently there is enlargement of a *pre—release* 
iron pool. Iron has been shown by other workers to 
induce the synthesis of ferritin, and the presence 
of a stimulated mechanism for ferritin synthesis 
within the reticulo-endothelial cells would result 
in the diversion of an increased percentage of 
erythrocyte iron into storage compounds.
The role of ascorbic acid in the metabolism of 
storage iron was investigated in guinea-pigs.
Ascorbic acid deprivation increased the total non­
haem iron concentration in the spleen and reduced 
it in the liver, and in both organs ferritin was 
diminished and haemosiderin increased. Replacing 
the ascorbic acid restored the normal distribution 
of iron between the two storage compounds, and in 
the spleen the total storage iron concentration
returned to control levels within Zh hours. Evidence
59was obtained in experiments with Fe that the
accumulation of iron In the spleen was due to a
diminished release from reticulo-endothelial cells.
59When Fe—labelled haemoglobin in denatured red
cells was injected, release of the isotope was 
inhibited in scorbutic animals. In contrast, -^Fe 
in the liver parenchymal cells after injecting 
labelled transferrin was released to a greater 
extent than in normals. These observations suggest 
that ascorbic acid is necessary for the release of 
iron from reticulo-endothelial cells but not from 
liver parenchymal cells. The vitamin also appears 
necessary for the prevention of excessive formation 
of haemosiderin from ferritin. These results, in 
addition, may explain certain ferrokinetic pecul­
iarities din patients with scurvy, and possibly 
also the predominantly reticulo-endothelial locali­
zation of the iron in Bantu subjects with siderosis.
Finally, the site of action of desferrioxamine 
was investigated in rats. Repeated injections of 
desferrioxamine significantly depleted the hepatic 
and splenic iron stores in normal rats, but not in 
rats which had been hypertransfused so as to reduce 
the rate of release of iron into the plasma. These 
observations indicate that the storage compounds 
ferritin and haemosiderin are not important direct 
donors of iron to desferrioxamine. Since plasma
iron is not bound by the chelate, some compound
or compounds on the pathway between the stores and
the plasma is probably the major immediate source.
It is postulated that the chelate acquires iron at
the cell membrane after it has been oxidized by
caeruloplasmin. By differentially labelling the
iron in hepatic parenchymal cells and reticulo—
59endothelial cells with Fe, evidence was obtained 
that desferrioxamine chelates iron in both cell
types
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